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ABSTRACT 
 
Staphylococcus lugdunensis is an opportunistic pathogen that can cause invasive infections 
suggesting an ability to circumvent host immunity. S. lugdunensis was shown to resist 
killing and persist within macrophages and acetylation of its peptidoglycan is important for 
this survival. This was consistent in vivo, as S. lugdunensis resides inside Kupffer cells for 
at least 16 hours post-infection in mice. Despite its capability for survival, S. lugdunensis 
is unable to replicate within phagolysosomes. Inhibiting phagolysosomal effectors allows 
S. lugdunensis to initiate replication, after which the bacteria escape phagosomal 
containment. Moreover, intracellular S. lugdunensis augments the growth S. aureus during 
co-infection. Eight hours following secondary infection of S. lugdunensis-infected mice 
with S. aureus, the S. aureus burden in the liver is amplified 10-fold above mice infected 
with S. aureus alone. It was found that the macrophage represents an undescribed reservoir 
for viable S. lugdunensis that can potentiate the virulence of S. aureus.  
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CHAPTER 1 – LITERATURE REVIEW 
 
1.1 Introduction to innate immunity 
Innate immunity is the first line of defense against the invasion of pathogens 
providing immediate, yet non-specific and relatively short-lived defense against infection. 
There are multiple components to innate immunity including physical/chemical barriers, 
the complement system, and phagocytic immune cells, that help prevent the invasion and 
spread of foreign microbes (1–3). Microbes are ubiquitous throughout the gastrointestinal 
tract and on the human skin, yet these bacteria rarely cause infection. Epithelial cells lining 
the skin, respiratory, gastrointestinal, urogenital tracts provide a physical barrier, which 
microbes are unable to cross. In addition to the physical barrier these environments also 
produce several chemical barriers, such as the low pH of the upper gastrointestinal tract. 
Moreover, human skin has a high amount of salt and fatty acids, which prevent the growth 
of many bacteria (4,5). However, when these barriers are breached by some means, 
pathogens will be able to bypass the physical and chemical barriers allowing them to invade 
into the host tissues. Additionally, many host tissues have another barrier to infection, 
known as colonization resistance, whereby commensal bacteria colonizing the host will 
compete with pathogens for nutrients and attachment sites (6,7). 
If pathogens are able to circumvent the initial barriers, they may then be faced with 
the humoral component of innate immunity including the complement system. The 
complement system consists of small soluble proteins produced in the liver and by a variety 
of immune cells. When activated the complement system results in the cleavage of C3 into 
C3a and C3b, the latter of which is deposited on the surface of pathogens (3). The 
deposition of C3b initiates a proteolytic cascade resulting in the formation of the membrane 
attack complex (MAC). The MAC forms transmembrane channels leading to osmotic lysis 
of the hosts cells (8). Furthermore, C3b functions as an opsonin leading to increased uptake 
of bacteria by phagocytic cells such as dendritic cells or macrophages (9). Although it is a 
critical component of innate immunity, the complement system was originally named for 
being exactly that – a complement to the phagocytic cells protecting against foreign 
microbes.  
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1.2 Phagocytes 
Phagocytes are specialized immune cells that employ the receptor-mediated process 
of phagocytosis to prevent the invasion and spread of microbes past the initial site of 
infection. There are several cell types that can be classed as phagocytes including 
neutrophils, dendritic cells and macrophages. Macrophages are the major phagocytic cell 
type that will be focused on throughout this project. The mechanisms by which phagocytes 
contribute to innate immunity will be reviewed further in the following sections. 
 
1.2.1 Macrophages 
Macrophages are specialized tissue-resident phagocytes that participate in the 
eradication of invading microbes. Monocytes, the precursor to recruited macrophages, are 
initially found in circulation, but during inflammation chemoattractant molecules, known 
as chemokines, are produced to recruit monocytes to the inflamed tissues (10). CCL2 is a 
major ligand expressed by endothelial cells in response to pro-inflammatory cytokines. 
This ligand will then bind to CCR2 which is found on monocytes, mediating 
chemoattraction (10,11). After chemoattraction the monocytes must migrate from 
circulation to the inflamed tissue. To accomplish this, monocytes are thought to follow the 
same process of leukocyte extravasation. In this process the cells in circulation bind to 
selectins in the blood vessel to begin rolling adhesion, then bind to integrins mediating tight 
adhesion, and lastly cytoskeletal rearrangements allow the cells to transmigrate out of the 
vessel into tissue (10).  Once in the inflamed tissue, the monocytes are differentiated into 
macrophages. These macrophages can take on different phenotypes based on the 
combination of cytokines present in the surrounding environment at the time of 
differentiation. These phenotypes fall on a spectrum of polarization states, on the one end 
the classically-activated M1 polarized macrophages, which are typically induced by the 
presence of pathogen-associated molecular patterns (PAMPs) along with inflammatory 
cytokines (IFN-g) exhibit enhanced microbicidal activity (12). On the opposite end of the 
polarization spectrum, the alternatively-activated M2 macrophages, induced by anti-
inflammatory cytokines (IL-10 and IL-4), and play a role in tissue remodelling and repair 
more so than infection control (12,13).  
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 Macrophages are critically important immune cells as they not only play a role in 
innate immunity but also contribute to the adaptive immune response. Macrophages 
possess a wide array of surface pattern recognition receptors (PRRs), which recognize and 
bind to conserved PAMPs allowing them to recognize and respond to an assortment of 
invading pathogens. In addition to the cell surface receptors macrophages are constantly 
reaching out and surveying the surrounding environment for signs of a threat using 
cytoplasmic extensions known as filopodia to engage foreign particles (14). This allows 
macrophages to effectively seek out and bind any foreign microbes that might pose a threat 
to the host, which will then be phagocytosed. 
 
1.2.2 Phagocytosis 
To prevent the spread of invading pathogens macrophages use the receptor-
mediated process of phagocytosis to internalize large particles into a membrane-bound 
compartment known as a phagosome (15). This process is initiated when foreign microbes 
or other particles engage receptors on the macrophage cell surface. Macrophages express 
a wide variety of PRRs such as Fcg receptors which recognize the Fc portion of human IgG 
antibodies on opsonized particles (16), or scavenger receptor A, which binds to lipoteichoic 
acid or lipopolysaccharide (LPS) (17). After the phagocytic receptor is engaged additional 
receptors will cluster around the bound ligand to activate signal transduction events leading 
to the initiation of internalization. FcgR-mediated uptake is the best understood model of 
phagocytosis, whereby clustering of receptors results in the cytosolic immunoreceptor 
tyrosine-based activating motif (ITAM) domains being phosphorylated (16). This 
phosphorylation initiates downstream signaling events causing rearrangement of the actin 
cytoskeleton and membrane fusion resulting in the foreign particle being internalized into 
the membrane-bound nascent phagosome (16,18). Phagocytosis is a rapid process taking 
only seconds to a few minutes from engagement of the phagocytic receptor to uptake of 
the microbe. This enables phagocytes play a critical role in the restriction of invading 
microbes, although phagocytosis in and of itself is not a microbicidal process. 
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1.2.3 Phagosome maturation 
Immediately after uptake, microbes will be contained within the nascent 
phagosome, which is a relatively innocuous environment with the membrane resembling 
the plasma membrane from which it was derived, and the lumen will be reflective of the 
extracellular environment at the time of uptake, making it insufficient for particle 
destruction (15). In order to degrade and eliminate engulfed particles the phagosome is 
rapidly trafficked through a maturation process resulting in the formation of a highly 
degradative and microbicidal compartment known as the phagolysosome (19). Phagosome 
maturation consists of several controlled membrane fusion and fission events resulting in 
significant biochemical changes to both the membrane and lumen of the phagosome. 
Importantly, each stage of phagosome maturation can be defined based on the membrane 
composition, which is altered by these fusion and fission events.  
The first major event in phagosome maturation is the accumulation of Rab5 in the 
phagosomal membrane, which facilitates fusion of the nascent phagosome with early 
endosomes (20) to form the early phagosome. Additionally, the phagosome acquires 
Vps34, a phosphatidylinositol-3 kinase (PI3K), which converts phosphatidylinositol to 
phosphatidylinositol-3-phosphate [PI(3)P], a key lipid involved in the maturation process 
(21). The early phagosome will then continue the maturation process in order to transition 
into a late phagosome. In this transition Rab5 is lost coinciding with the acquisition of Rab7 
and generation of phosphatidylinositol-4-phosphate [PI(4)P] in the phagosomal membrane 
(20,22). Additionally, the late phagosome can be characterized by the presence of the 
lysosomal associated membrane protein 1 (LAMP-1), which is an integral membrane 
protein typically found in the membranes of late endosomes and lysosomes (23). The exact 
role of LAMP-1 in the maturation process remains unclear, although it is known that 
Neisseria gonorrhoeae is able to specifically degrade LAMP-1 to promote its intracellular 
survival, clearly implicating LAMP-1 as an essential factor for restriction (24). Rab7 plays 
a critical role in maturation as it is responsible for recruiting several effector proteins 
including Rab7-interacting lysosomal protein (RILP) and oxysterol-binding protein–
related protein 1 (ORPL1), which coordinate the trafficking and fusion of lysosomes with 
the late-phagosome (25,26). The fully mature phagolysosome is biochemically defined by 
the presence of LAMP-1 in the membrane, along with the presence of lysosomal hydrolases 
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and a highly acidic lumen (1,15,27). The phagolysosome is the end result of a carefully 
controlled maturation process and is the ultimate microbicidal organelle in the cell. 
 
1.2.4 Antimicrobial effectors of the phagolysosome 
Foreign particles or microbes will be engaged and taken up by macrophages into a 
nascent phagosome, which is initially innocuous but rapidly matures to become a highly 
microbicidal compartment.  The mature phagolysosome employs a variety of restrictive 
and degradative mechanisms including, but not limited to, low pH, nutrient limitation, 
digestive enzymes, and reactive oxygen species (ROS) (1). These effectors function to 
restrict and eliminate microbes contained within the compartment.  
In order to acidify the phagosome vacuolar-ATPases work to pump protons into the 
lumen of the phagosome, which accumulate over time, decreasing the pH of the 
compartment (28). Importantly, maturing phagosomes have reduced passive proton 
permeability, preventing proton leakage and thereby allowing for continued acidification 
throughout maturation (28). This allows the pH of the phagosome to decrease from ~7 to 
4.5 over the course of the maturation process. The decreased pH of the phagolysosome can 
directly restrict the growth of many bacteria, but also functions in concert with NADPH 
oxidase to produce ROS to further damage the luminal contents (1,29). Furthermore, 
several digestive enzymes such as the proteolytic cathepsins or the hydrolytic lysozyme 
are delivered to the phagosomal lumen throughout the maturation process. These enzymes 
function to kill and degrade any contained microbes and notably many of these enzymes 
exhibit optimal activity under the low pH conditions of the mature phagolysosome (30,31). 
Macrophages also employ antimicrobial mechanisms such as nutrient limitation, 
which is a restrictive but not degradative process. Nutritional immunity is a process 
whereby the host sequesters essential nutrients making them inaccessible to invading 
microbes hindering their growth and virulence (32). A key effector of nutritional immunity 
in macrophages is the natural resistance-associated macrophage protein 1 (NRAMP1), 
which gets recruited to phagosomal membranes during infection (33,34). NRAMP1 
functions to actively pump divalent cations (Mn2+, Zn2+, and Fe2+) out of the phagosomal 
lumen making them inaccessible to the phagocytosed bacteria (35,36). These nutrients are 
essential for several bacterial processes and their exclusion limits the growth and virulence 
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of many bacterial species. The growth-arrested bacteria are then killed by the array of 
microbicidal effectors previously described allowing for effective elimination of the 
phagosomal contents. 
 
1.2.5 Mechanisms pathogens use to overcome macrophages 
Macrophages are an important part of the initial response to invading microbes, but 
in the case of disease the causative pathogens clearly have adapted to survive when 
challenged by these phagocytic cells. In order to overcome macrophages, pathogens have 
acquired a variety of mechanisms allowing them to survive or circumvent the antimicrobial 
effectors previously discussed. These strategies can differ widely from surviving in the 
phagolysosome, preventing maturation to a phagolysosome, or escaping the phagosome 
entirely. Regardless of the mechanism of action, to cause disease a pathogen must be able 
to overcome the initial challenge by host macrophages. 
Mycobacterium tuberculosis is a widespread pathogen that is well-known for its 
ability to survive within host macrophages, by blocking the maturation of M. tuberculosis 
containing phagosomes. M. tuberculosis is contained in Rab5-positive early phagosomes 
but inhibits the recruitment of Rab5 effectors such as Vps34, which prevents the 
accumulation of PI(3)P (1,37). The lack of PI(3)P accumulation on the early phagosomes 
prevents maturation to late and phagolysosomal stages (38), providing an environment 
much more conducive to the growth and survival of M. tuberculosis. In contrast to M. 
tuberculosis, which modifies the phagosome to make it more habitable, Listeria 
monocytogenes is able to altogether escape phagosomal containment, while remaining 
within the macrophages allowing for its survival (1,39). In order to escape phagosomal 
containment, L. monocytogenes encodes listeriolysin O (LLO), a pore forming toxin, and 
two distinct phospholipase C enzymes, allowing for dissolution of cellular membranes and 
escape from the phagosomal compartment (40,41). Furthermore, some pathogens such as 
Staphylococcus or Streptococcus species encode specialized machinery that allow for 
enhanced survival within mature phagolysosomes (42,43).  
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1.3 Staphylococcus aureus  
S. aureus is a Gram-positive facultative anaerobe found persistently colonizing the 
nose of roughly 30% of the human population. It is also a major cause of skin and soft 
tissue infections, sepsis, and osteomyelitis (44). The success of S. aureus as a major human 
pathogen is largely due to its extensive arsenal of virulence factors that enable S. aureus to 
colonize and infect virtually every tissue in the human body. In addition to numerous 
toxins, S. aureus encodes several factors enabling it to resist immune attack promoting 
enhanced survival within the host. Furthermore, S. aureus has also developed resistance to 
several types of antibiotics complicating treatment and ultimately leading to the evolution 
of methicillin-resistant S. aureus (MRSA). In the 1990s invasive MRSA emerged within 
the community setting with the strain USA300 in particular reaching pandemic status 
across North America. Infections caused by invasive MRSA come with approximately a 
20% mortality rate making it the leading cause of death by an infectious agent in the United 
States (45,46). S. aureus is a major burden on the healthcare system and the lack of an 
effective vaccine for this species is a significant concern, underscoring the need for 
continued investigation into the pathogenic mechanisms of S. aureus. 
 
1.3.1 S. aureus virulence factors 
S. aureus is a prolific pathogen that can infect virtually any part of the human body 
owing to its arsenal of virulence factors. These virulence factors serve a variety of purposes 
from immune evasion to leukocyte killing and antimicrobial resistance to promote bacteria 
survival and spread. S. aureus is able to carefully regulate the production of its virulence 
factors, initially employing factors for immune evasion and survival in order to adapt to 
and colonize different tissues. After colonization, S. aureus can proliferate, and initiate 
toxin production allowing for invasion and spread past the initial site of infection and 
eventually to a new host. 
A key virulence factor allowing for immune evasion is protein A, which is able to 
non-specifically bind the Fc region of IgG antibodies (47). By binding antibodies in the 
reverse direction, protein A provides a protective coat on the surface of S. aureus 
preventing opsonization and uptake by phagocytes (48). Additionally, by blocking 
antibody-mediated responses, protein A contributes to the ability of S. aureus to re-infect 
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the same host (49). S. aureus also encodes multiple cell wall modification systems allowing 
for resistance to immune effectors such as lysozyme and cationic antimicrobial peptides 
(CAMPs), to promote bacterial survival. The dltABCD encodes enzymes that function to 
esterify D-alanine to the teichoic acids thereby contributing to a net positive charge of the 
cell wall (50,51). The increased charge helps to repel CAMPs such as cathelicidins, which 
normally bind to the bacterial surface and insert into the membrane, killing the cell (52). 
The oatA enzyme is another cell wall modifying enzyme encoded by S. aureus. OatA 
functions to O-link an acetyl group to the N-acetylmuramic acid of the peptidoglycan (53). 
This acetate sterically hinders lysozyme, preventing it from binding and hydrolyzing the 
glycosidic bonds in the peptidoglycan (54). These modification systems are important for 
the ability of S. aureus to survive both intra- and extracellularly during an infection (55). 
After colonizing host tissues S. aureus will initiate toxin production through the 
accessory gene regulator (agr) quorum sensing system, which is a global regulator of toxin 
production (56). S. aureus can produce several cytolytic toxins in order to combat immune 
cells leading to inflammation and tissue damage. The alpha-, beta-, and delta toxins along 
with the bi-component leukocidins are some of the major hemolytic and cytolytic toxins 
that promote severe infections by S. aureus. The a-toxin, also known as a-hemolysin, has 
a b-barrel structure allowing it to insert into and form pores in cellular membranes leading 
to apoptosis (57). The b-toxin functions as a sphingomyelinase making it toxic to cells such 
as erythrocytes, fibroblasts, and macrophages, which have sphingomyelin exposed at the 
cell surface (58). The d-toxin produced by S. aureus is part of the phenol soluble modulin 
peptide family with an alpha helical amphipathic structure (59). This structure allows the 
d-toxin to function similar to a detergent where it is able to non-specifically insert into and 
disrupt cellular membranes resulting in cell lysis (59). The bi-component leukocidins are 
thought to be important for targeting and lysing immune cells including neutrophils and 
macrophages (60,61). Each polypeptide of these bi-component toxins binds to the cell 
surface as a monomer before coming together and oligomerizing to form an octameric 
transmembrane b-barrel pore lysing the cell (62). These toxins are carefully regulated to 
work in concert with several other virulence determinants produced by S. aureus to help 
the bacteria to overwhelm or otherwise circumvent the hosts immune response and cause 
tissue damage contributing to productive infection allowing for bacterial spread.  
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1.3.2 Interactions between S. aureus and macrophages 
 While S. aureus has been traditionally thought of as an extracellular pathogen, it 
has become abundantly clear that S. aureus is also able to successfully occupy an 
intracellular niche within multiple cell types (63–65). Specifically, S. aureus has become 
well known for its ability to survive internalization and take up residence within 
professional phagocytes including macrophages (42,66). S. aureus is known to survive 
intracellularly within both murine and human macrophages in vitro for extended periods 
of time. Furthermore, infected macrophages maintained in the presence of extracellular 
antibiotics were able to contain S. aureus for much longer than those without antibiotics, 
despite the antibiotic being membrane-impermeant (42,65). Although the mechanism by 
which extracellular antibiotic can restrict intracellular S. aureus has not been characterized, 
presumably the host cell would uptake antibiotic through pinocytosis resulting in delivery 
of antibiotic to the S. aureus containing phagosome. Moreover, extracellular antibiotic 
would immediately kill any bacteria emerging from host cells, thereby preventing 
intoxication by extracellular S. aureus. It is worth noting that fluorescence microscopy has 
been used to confirm that S. aureus in fact resides within fully mature phagolysosomes in 
vitro without succumbing to the plethora of microbicidal effectors in these compartments 
(42,67,27). The ability of S. aureus to survive within macrophages is consistent in vivo, as 
S. aureus has been shown to be taken up by specialized liver-resident macrophages called 
Kupffer cells within minutes of intravenous injection of bacteria in mice (68). S. aureus is 
capable of readily proliferating within macrophages both in vitro and in vivo eventually 
leading to host cell death and release of the bacteria, which can then disseminate resulting 
in further infection.  
 
1.4 Staphylococcus lugdunensis 
 S. lugdunensis is an opportunistic pathogen that behaves similarly to S. aureus both 
in the lab and clinically and will be the main species of focus in this work. S. lugdunensis 
is a Gram-positive, facultative anaerobe that asymptomatically colonizes human skin, 
predominantly on the lower half of the body, although some strains are also known to 
colonize the nasal cavity (69). One key difference between S. aureus and S. lugdunensis is 
that S. lugdunensis lacks a secreted clotting factor and is therefore classed as a coagulase 
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negative species (CoNS). However, it should be noted that some strains of S. lugdunensis 
have been found to possess a membrane-bound clotting factor, which can cause it to 
occasionally test positive in the rapid coagulase tests that are frequently used in many 
clinical settings (70). Furthermore, S. lugdunensis is known to cause a variety of skin and 
soft tissue infections very similar to those caused by S. aureus including, but not limited 
to, abscesses, wound infections, osteomyelitis, and endocarditis (71–73). This makes it 
understandable that S. lugdunensis infections are occasionally misdiagnosed as S. aureus 
(74), leading to an underestimation of the true burden of S. lugdunensis infections. 
Although S. lugdunensis remains a less frequent cause of infection than S. aureus, the 
infections caused by S. lugdunensis have the potential to be highly invasive and lethal, 
closely resembling infections caused by S. aureus (70). Furthermore, S. lugdunensis is 
slowly becoming resistant to clinically relevant antibiotics which will lead to increased 
difficulties in treating infections caused by this species (75–77). 
Despite the fact that S. lugdunensis was first isolated in 1988, it only recently has 
begun to gain notoriety as a significant pathogen with the capability to cause serious 
infection (78). Recent improvements in diagnostics through increased implementation of 
mass spectrometry based diagnostic methods for bacterial identification has enhanced the 
detection of S. lugdunensis in clinical samples (76,79). As more clinics adopt mass 
spectrometry-based methods the true burden of S. lugdunensis infections will be revealed 
(76). Due to the fact that S. lugdunensis has been an underappreciated pathogen, 
remarkably few virulence factors have been identified or characterized at this point in time. 
The following section will discuss some of the known virulence factors and pathogenic 
mechanisms of S. lugdunensis.  
 
1.4.1 S. lugdunensis virulence factors 
Currently only a few of S. lugdunensis’ virulence factors have been characterized, 
however, those virulence factors that have been characterized are known contribute to its 
ability to cause invasive infections. It is worth noting that many of the virulence factors 
encoded by S. lugdunensis are very similar to those found in S. aureus, however, S. 
lugdunensis lacks many of the toxins produced by S aureus (80). Similar to S. aureus, S. 
lugdunensis employs multiple cell wall modification systems in order to resist host 
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defenses. Importantly, S. lugdunensis encodes both oatA and the dlt operon described 
previously, thereby conferring resistance to lysozyme and CAMPs respectively (55,81). 
Additionally, S. lugdunensis possesses multiple adhesion proteins allowing effective 
colonization of host tissues. Two of the major adhesion proteins utilized by S. lugdunensis 
are the von Willebrand factor binding protein (vWbl) and fibrinogen-binding protein (fbl) 
(82,83). As its name suggests vWbl binds to von Willebrand factor (vWf), a glycoprotein 
found on platelets and cells (84). Normally vWf allows for coagulation following vascular 
injury (84), but when the vasculature becomes damaged during an infection vWf can be 
exploited by S. lugdunensis allowing for adhesion. Furthermore, the fbl produced by S. 
lugdunensis is structurally and functionally similar to clumping-factor A produced by S. 
aureus, which binds to host fibrinogen, a major plasma protein and component of the 
extracellular matrix (85,86). Binding to fibrinogen allows S. lugdunensis to adhere to a 
wide variety of host tissues and is important for the initiation of biofilm formation (87). 
Moreover, the expression of multiple adhesins could conceivably be linked to the enhanced 
ability of S. lugdunensis to infect human heart valves.  
The expression of virulence factors is a carefully regulated process and after 
effectively colonizing host tissues S. lugdunensis must then initiate toxin production to 
cause tissue damage allowing for spread passed the initial site of infection. Despite lacking 
many of the secreted toxins encoded by S. aureus, S. lugdunensis retains the ability to 
invade deep into host tissues causing severe infections. Importantly, S. lugdunensis is 
known to encode three S. lugdunensis synergistic hemolytic (SLUSH) peptides, which 
together function akin to the S. aureus d-toxin, disrupting cellular membranes resulting in 
host cell lysis (59,80,88). SLUSH-ABC are three highly similar peptides consisting of 43 
amino acids that cause hemolysis, but there is also a hypothetical 24-amino acid peptide of 
unknown function upstream of SLUSH-A (70). Furthermore, the SLUSH peptides are 
known to exhibit synergistic activity with the b-toxin from S. aureus, leading to enhanced 
lysis of red blood cells on sheep blood agar (88). The SLUSH peptides in addition to the 
other virulence factors encoded by S. lugdunensis are tightly regulated to allow for effective 
colonization of host tissues, leading to invasive infections with devastating outcomes. 
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1.4.2 Antimicrobial resistance in S. lugdunensis 
In contrast to S. aureus, which is well known for its status as an antibiotic resistant 
superbug, S. lugdunensis has been relatively slow to gain antibiotic resistance, largely 
remaining susceptible to routinely used drugs. Various studies have reported increasing 
rates of penicillin resistance in clinical S. lugdunensis isolates over time starting below 4% 
(89), but more recent reports found that up to 50-85% of isolates in Taiwanese hospitals 
were found to be resistant to penicillin (75,90).  The increase in resistance to penicillin is 
concerning, but a much more worrying matter is the emergence of S. lugdunensis strains 
carrying the mecA gene for methicillin resistance (75,77,91).  These methicillin resistant S. 
lugdunensis isolates were first detected in east Asia but have now been found on four 
separate continents (74,77,91,92). Interestingly, despite the spread of S. lugdunensis strains 
carrying mecA around the globe, the infections by mecA-positive S. lugdunensis strains 
remains fairly rare. It is fortunate that even in the rare case of methicillin resistance all 
isolates have remained sensitive to killing by vancomycin (92), although this remains a last 
resort treatment and is not routinely administered. This highlights the importance of 
antibiotic resistance in S. lugdunensis as resistance genes have spread globally, giving S. 
lugdunensis the potential to accumulate multiple drug resistances similar to S. aureus, 
further complicating treatment of invasive S. lugdunensis infections.  
 
1.5 Microbial interactions 
Microorganisms are found virtually everywhere in the world and while research 
frequently focuses on the interactions between a single species and its host, individual 
species are rarely found in isolation and various species frequently interact with each other 
by several different mechanisms. Interspecies interactions can elicit many different 
outcomes but can generally be classed as either cooperative or competitive interactions 
(93,94). Competitive interactions are more common in the context of a battle between 
species during colonization, whereas cooperative interactions are more relevant in the 
context of mixed infections. These interactions are especially important when considering 
the effect on opportunistic pathogens where the colonization, growth and virulence of each 
species can be reduced or enhanced. Previously S. lugdunensis and S. aureus have been 
shown to interact with each other, undergoing both competitive and cooperative 
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interactions depending on the environmental context in which the species engage each 
other (95,96). Furthermore, both S. aureus and S. lugdunensis isolates have each been 
reported to regularly be found as part of mixed infections with an assortment of other 
species (70,97), and occasionally with each other (72). The following sections will further 
discuss general mechanisms and outcomes of microbial interactions, as well as specific 
interactions between S. lugdunensis and S. aureus.  
 
1.5.1 Competitive interactions 
As previously mentioned, bacterial species are rarely found in isolation and are 
usually found as part of a much larger polymicrobial community. Within this community 
each species must compete with the others to establish its own niche. In this competition 
microbes will employ both offensive and defensive factors in an ongoing battle for 
colonization. One mechanism of competition is through the use of secreted factors to 
interrupt normal signaling events of neighbouring species, perturbing downstream 
processes potentially required for growth or virulence. Another common mechanism used 
by bacteria to outcompete other species is to produce specialized metabolites that function 
as antibiotics to directly kill off other microbes in the local environment (98). Streptomyces 
species are well known for their production of specialized metabolites that function as 
antibiotics, producing over two-thirds of clinically-relevant antibiotics (99,100). 
Importantly, species that produce antimicrobial metabolites must also encode resistance 
mechanisms to avoid self-killing by these metabolites. This serves as a reminder that 
competition is not only about offense, as successful competitors must also employ 
resistance factors to survive attack from other species. Bacterial species that are better 
competitors will be much more effective colonizers and can possibly invade into host 
tissues to cause infection.  
Many different staphylococcal species are known to inhabit the human skin with 
overlapping niches ultimately resulting in interspecies competition between the various 
staphylococci (101). Like many species, staphylococcal species work to block key 
signalling events in nearby species to diminish their growth. Specifically, staphylococcal 
bacteria will block quorum-sensing signals from other staphylococcal species in the 
surrounding area (102). Indeed, the autoinducing peptide produced by the agr system in S. 
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epidermidis is known to be a potent inhibitor of the agr system in S. aureus (102,103). This 
competitive advantage has been suggested as a reason for the predominance of S. 
epidermidis on human skin (104). In contrast to S. epidermidis, which modulates the 
growth and virulence of S. aureus, S. lugdunensis is able to directly kill co-colonizing S. 
aureus. Initially it was noticed that although both S. aureus and S. lugdunensis colonize the 
nasal cavity, but carriage of S. lugdunensis was associated with lower rates of S. aureus 
colonization, suggesting competitive inhibition (96). Along with this observation it was 
discovered that nasal colonizing strains of S. lugdunensis produce a novel antibiotic 
product called “lugdunin,” which was bactericidal towards S. aureus (96). While S. aureus 
is sensitive to competitive inhibition by other staphylococcal species, it does encode 
defensive mechanisms allowing it to overcome competition from other species. One 
example of a resistance mechanism employed by S. aureus when faced with competition 
is the expression of catalase in the presence of Streptococcus pneumoniae invasion (105). 
S. pneumoniae produces H2O2 in its local environment to kill competing bacteria, however, 
S. aureus produces catalase, which functions to break H2O2 into water and oxygen 
(105,106). It has been shown that strains of S. aureus deficient for catalase are less able to 
resist killing by S. pneumoniae in vitro, clearly demonstrating the role of catalase for 
competition during colonization (105). Competition between bacterial species is common 
and takes on many different forms, but ultimately the best competitors will be able to 
overwhelm other species in order to promote their own successful colonization. 
 
1.5.2 Cooperative interactions 
Many bacterial exoproducts could be considered cooperative as they benefit the 
producing species, but also frequently confer some benefit to other microbes in the vicinity. 
Exotoxins and siderophores are two examples of products that when secreted have the 
potential to benefit multiple species (107,108). Exotoxins produced during infection can 
bring about tissue damage as well as lysing host cells including leukocytes and erythrocytes 
liberating nutrients, which are normally inaccessible. This then offers opportunistic 
pathogens, that may not secrete their own exotoxins, a chance to gather these nutrients and 
invade the damaged host tissues. For example, S. aureus a-toxin is known to target 
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macrophages promoting the growth and dissemination of multiple species of Gram-
negative bacteria during co-infection (97). Moreover, the need to gather nutrients such as 
iron, which is normally sequestered by the host, is essential for nearly every bacterial 
pathogen (109,110). To effectively acquire iron, several pathogenic species produce 
siderophores that are able to bind and liberate the ferric iron from host proteins that 
normally sequester any available iron (111). The siderophores complexed with iron can be 
taken up by the bacteria and the iron can be used as it is required for growth and virulence 
of multiple pathogens such as S. aureus, Pseudomonas aeruginosa, and Francisella 
tularensis (112–114). While siderophores may not be an intentionally cooperative 
interaction, they benefit the producing species, and are also able to benefit nearby bacteria 
that express the corresponding receptors required for uptake. Many microbes encode 
receptors for the uptake and use of siderophores that are produced by other species known 
as “xenosiderophores” (95,108). P. aeruginosa is noteworthy for it not only produces two 
of its own siderophores, pyoverdine and pyochelin, but also encodes receptors for several 
other xenosiderophores (115) This serves to highlight the contribution of interspecies 
interactions to the growth and dissemination of multiple species through tissue damage and 
nutrient acquisition.  
Staphylococcal species are particularly intriguing as they frequently compete, as 
described previously, but are also able to cooperate with each other under certain 
conditions. As discussed earlier S. lugdunensis and S. aureus cooperate through the 
production of hemolytic exotoxins. S. lugdunensis secretes the SLUSH peptides, which are 
minorly hemolytic on their own, but in the presence of S. aureus b-toxin are able to cause 
potent red blood cell lysis (88). Furthermore, these two species cooperate through the 
utilization of xenosiderophores. S. aureus produces and secretes two polycarboxylate 
siderophores staphyloferrin A and B (SA and SB) to bind ferric iron (116,117). The 
siderophores then bind to their cognate receptors on the bacterial surface, HtsABC is the 
receptor for SA and SirABC is the receptor for SB, which are powered by the ATPase 
FhuC to import iron-siderophore complex (118,119). S. lugdunensis does not produce its 
own siderophores but does encode the HtsABC and SirABC receptors along with FhuC 
allowing for import and utilization of SA and SB produced by S. aureus (95). Moreover, 
coculture experiments have shown that the use of S. aureus’ siderophores enhance the 
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growth of S. lugdunensis without compromising the growth of S. aureus confirming S. 
lugdunensis is not parasitizing S. aureus, rather they are truly cooperating (95). The 
synergistic effect of toxins from S. aureus and S. lugdunensis in addition to the ability of 
S. lugdunensis to utilize SA and SB from S. aureus shows that these species are clearly 
able to cooperate in vitro. Taken with the fact that S. lugdunensis is frequently found as 
part of mixed culture infections, suggests that S. lugdunensis is capable of cooperating with 
a number of different species including S. aureus under favourable conditions. 
 
1.6 Project rationale and hypothesis 
S. lugdunensis has emerged as an important pathogen with the capacity to cause a 
variety of invasive infections that are clinically indistinguishable from those caused by S. 
aureus. Until recently, S. lugdunensis has been underappreciated as a pathogen due to a 
combination of factors including its misdiagnosis as S. aureus, its frequent occurrence in 
mixed infections, and a lack of effective identification in clinical samples. S. lugdunensis 
is recognized for its enhanced virulence compared to other CoNS and the emergence of 
antibiotic resistant strains is making these invasive infections increasingly difficult to treat. 
Despite the significance of S. lugdunensis, remarkably little is known about the 
pathogenesis of this species and its interactions with macrophages have not yet been 
investigated. The observation that S. lugdunensis is able to cause infections similar to S. 
aureus and is regularly found in mixed infections, led me to hypothesize that S. 
lugdunensis, like S. aureus, must be able to overcome immune restriction and resist killing 
by host macrophages allowing for persistence within these cells, which then sensitizes the 
host cells to subsequent infection by other pathogenic species such as S. aureus 
 
1.7 Research objectives 
To investigate my hypothesis, I pursued the three following research objectives: 
1. Determine the subcellular location of S. lugdunensis within macrophages, and the 
specific factors that allow S.  lugdunensis to survive within these cells. 
2. Determine the immune mechanisms restricting the growth of S. lugdunensis and the 
outcome upon the initiation of intracellular replication. 
3. Characterize the interactions of S. lugdunensis and S. aureus with macrophages in the 
context of a co-infection. 
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CHAPTER 2- MATERIALS AND METHODS  
 
 
2.1 Reagents 
Roswell Park Memorial Institute 1640 medium (RPMI) and fetal bovine serum 
(FBS) were from Wisent Inc. (St. Bruno, QC, Canada). Paraformaldehyde 16% solution 
and #1 thickness round cover glass slips (18mm diameter) were from Electron Microscopy 
Sciences (Hatfield, PA, USA). The Cell Proliferation Dye eFluor® 670 was from 
eBiosciences. 3.14μm silica beads were from Bangs Laboratories (Fishers, IN, USA). 
Lyophilized human IgG was from Sigma Aldrich (St. Louis, MS, USA). Fluorescent 
tetramethylrhodamine conjugated wheat germ agglutinin (TMR-WGA) and FITC-Avidin 
488 were from Molecular probes, ThermoFisher Scientific.  The rat anti-mouse LAMP-1 
antibody (clone 1D4B) and the mouse anti-human LAMP-1 antibody (clone H4A3) were 
obtained from the Developmental Studies Hybridoma Bank at the University of Iowa. Goat 
anti-rat Alexa Fluor® 488 IgG, goat-anti rat and goat anti-human Cy3 conjugated IgG were 
all purchased from Jackson Immunoresearch. For cell-culture recombinant human M-CSF, 
IFN-γ, GM-CSF were purchased from Peprotech and LPS was from Sigma-Aldrich. 
Concanamycin A (ConA), Pepstatin A and Antipain were purchased from Santa Cruz 
Biotechnology. Diphenyleneiodonium (DPI) was purchased from Tocris Bioscience.   
 
2.2 Bacterial Strains and Culture Conditions 
S. aureus strain USA300 (plasmid cured) (120), Micrococcus luteus (42), S. 
lugdunensis HKU09-01 (121), S. lugdunensis N920143 (81), and S. lugdunensis DoatA 
mutant derived from HKU09-01 (this study) were used in this study (Table 1). Bacteria 
were routinely cultured at 37°C in tryptic soy broth (TSB) (Difco) with shaking or on TSB 
agar (1.5% w/v). When needed S. lugdunensis carrying a constitutive GFP/mCherry 
expression vector pRSA-GFP/pAH9 (122) was cultured in the presence of erythromycin 
(3 μg/mL) and lincomycin (20 μg/mL). When necessary the staphylococcal-selective 
medium mannitol salt agar (MSA) was also used and bacteria were cultured on MSA at 
37°C. 
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Table 1. Bacterial strains and plasmids used in this study 
Strain or Plasmid   Description          Source/Reference 
Strains 
Micrococcus luteus               
H3129   Human skin commensal species           Laboratory stock 
Staphylococcus aureus 
USA300              USA300 LAC; MRSA cured of antibiotic              Laboratory stock 
resistance plasmids         
    
Staphylococcus lugdunensis 
HKU09-01  Sequenced WT strain isolated from human skin         Tse 2010 (121) 
   infection, Hemolytic on blood agar 
DoatA   markerless deletion of o-acetyltransferase in                This study 
   HKU09-01 background 
N920143 Sequence WT strain isolated from a                             Heilbronner 
breast abscess Non-hemolytic on blood agar                  2011(81) 
Plasmids 
pRSA-GFP  S. lugdunensis GFP constitutive expression             Sayedyahossein    
vector pRSA promoter, erythromycin resistance          2014 (122)    
pAH9   S. lugdunensis mCherry constitutive expression     Boles 2008 (123) 
   vector, SarA promoter, erythromycin resistance 
pCG44   S. aureus GFP constitutive expression vector         Gries 2016 (124) 
   SarA promoter, chloramphenicol resistance  
pLactC2-RFP  Mammalian expression vector encoding.                   S. Grinstiein 
   lactadherin-C2 domain fused to RFP 
pKOR1-DoatA Allelic replacement plasmid for deletion of oatA       This study  
 
 
2.3 Mammalian Cell Cultures 
RAW 264.7 macrophages were from the American Type Culture Collection. RAW 
264.7 macrophages were routinely cultured in RPMI 1640 (Wisent) buffered with sodium 
bicarbonate and 25mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) 
supplemented with 5% (v/v) non-inactivated FBS (Wisent). Macrophages were passaged 
by cell scraping and grown at 37°C in the presence of 5% CO2. RAW macrophages were 
passaged for no longer than 6 weeks prior at which time new cells were revived from liquid 
nitrogen.    
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Primary human macrophages were derived from peripheral blood monocytes 
isolated from healthy volunteer blood samples. Monocytes were isolated as previously 
described (42). In brief, monocytes were enriched for by virtue of their rapid adhesion to 
glass coverslips. Differentiation of adhered monocytes was accomplished by culturing cells 
as described above in RPMI supplemented with 10% (v/v) non-inactivated FBS and 
antibiotics. For the differentiation of M0 macrophages adhered monocytes were cultured 
in the presence of recombinant human M-CSF (10ng/mL) for 5 days followed by RPMI 
containing 10% (v/v/) FBS and M-CSF without antibiotics for an additional 2 days. 
Macrophages were used from days 7 to 10. To generate primary M1 polarized primary 
human macrophages adhered monocytes were cultured as above however recombinant 
human GM-CSF (20ng/mL) was used. At day 5 post-isolation the medium was replaced 
with RPMI containing 10% (v/v) FBS without antibiotics but containing GM-CSF (20 
ng/mL), recombinant human IFNγ (10 ng/mL) and LPS (250 ng/mL). Cells were used from 
days 7 to 10. 
 
2.4 Infection Assays and Enumeration of Gentamicin Protected Bacteria 
All macrophages adhered to glass coverslips were infected with bacteria at a 
multiplicity of infection (MOI) of ten unless otherwise stated. Bacteria were grown 
overnight in TSB then pelleted and re-suspended in serum free RPMI and diluted to the 
appropriate cell density. Bacteria were then added to macrophages that had been cultured 
overnight in individual wells of 12 well tissue culture plate. To synchronize phagocytosis 
tissue culture plates were centrifuged at 277 x g for 2 minutes and then incubated at 37°C 
with 5% CO2 for 30 minutes. Next, cells were washed with PBS and the medium was 
replaced with serum free RPMI containing gentamicin at 100 μg/mL for 60 minutes. For 
some infection experiments either 0.02% or 0.002% Triton X-100 was added to the 
macrophages after treatment with gentamicin to release the bacteria from the macrophages. 
To enumerate gentamicin-protected cells at 1.5 hours post-infection the 
macrophages were washed with PBS after gentamicin treatment and then lysed with sterile 
water and 0.01% (v/v) Triton X-100 in PBS. For infections longer than 1.5 hours infected 
cells were washed with sterile PBS and then incubated in RPMI containing 5% (v/v) FBS 
without gentamicin. At 24 hours post-infection or longer as necessary the culture medium 
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was collected and centrifuged to collect any bacteria having escaped from macrophages. 
Adherent macrophages were lysed as described above and the cell pellet from the culture 
medium was re-suspended in the Triton solution containing lysed macrophages and 
gentamicin protected bacteria. The samples were serially diluted and plated to determine 
the number of colony forming units. 
In some instances, mock infections were performed as controls. The input bacterial 
samples were prepared identically to those above but were added to individual wells of a 
tissue culture plate without macrophages. The samples were grown in RPMI with 5% (v/v) 
FBS at 37°C with 5% CO2. These cells were not treated with gentamicin but were collected 
at 1.5 and 24 hours post inoculation and were diluted and plated as above.  
 
2.5 Biotinylation of bacteria. 
Bacteria were surface biotinylated as previously described (125). In brief, bacteria 
from an overnight culture were pelleted and washed in PBS pH 8.0. Next, the bacterial 
pellet was re-suspended in 1 ml of PBS pH 8.0 containing 0.1 mg EZ-Link-NHS-LC Biotin 
(Thermo Scientific) and incubated at room temperature for 10 min. Bacteria were then 
pelleted and incubated for 2 min with 1 mL of TSB to quench any unreacted biotin. After 
washing with PBS bacteria were re-suspended in serum free RPMI and used for infections 
as described above.  Biotinylated bacteria remaining outside macrophage were detected by 
adding eBioscience™ streptavidin-FITC (Thermo Scientific). 
 
2.6 Construction of a S. lugdunensis oatA mutant 
Allelic replacement was performed using the pKOR1 plasmid as previously 
described (126). In brief, the oatA-Attb1/oatA5’R, and the oatA3’F/oatA-Attb2 primer 
pairs (Table 2) were used to PCR amplify 900-1100 base pair regions upstream and 
downstream of the oatA gene. The fragments were cloned into the pKOR1 plasmid to 
generate the pKOR1ΔoatA plasmid. This plasmid was obtained in E. coli DH5a and 
passaged through E. coli SL01 to allow for proper DNA methylation so it could be 
transformed into S. lugdunensis HKU09-01. Chromosomal recombination then resulted in 
the deletion of the oatA gene from S. lugdunensis. Chromosomal deletions were confirmed 
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by PCR amplification using the forward and reverse primers oatA-Check-F/R that anneal 
to the chromosome flanking the entire the regions of homology. 
 
 
Table 2. Oligonucleotides used for allelic replacement 
Name     Sequence* 
oatA-Attb1    5’GGGGACAAGTTTGTACAAAAAAGCAGGCTCAACAAATTTT 
                              TGGAGG 3’  
oatA5’R    5’GGACCTCCGCGGCTTAACTTGTAGTTCCG 3’ 
oatA3’F    5’ GGACCTCCGCGGCCATTGAACAAACAGAAAAAG 3’ 
oatA-Attb2    5’GGGGACCACTTTGTACAAGAAAGCTGGGTCCAGGATTTAC 
                              AACACATG 3’ 
oatA-Check-F    5’ CAAATTTTATGTTATAGTTTCTAG 3’ 
oatA-Check-R    5’ GTTCTAAATTTAATGGAACGGGG 3’ 
 Used for deletion of oatA from S. lugdunensis HKU09-01 
* Restriction sites are underlined 
 
2.7 Lysozyme MIC 
Wild-type and oatA deficient S. lugdunensis bacteria were streaked onto TSA plates 
and grown overnight at 37°C. Isolated colonies were inoculated into individual glass test 
tubes containing 5mL TSB, in triplicate for each strain, and grown overnight with shaking. 
The next day the bacteria were pelleted and washed with sterile 1xPBS and diluted to an 
OD600nm of 0.5. Next a 1 in 100 dilution of these bacterial suspensions (final OD600nm 
of 0.005) was used to inoculate RPMI supplemented with 0.5% (w/v) casamino acids in 
the presence of lysozyme. Two-fold dilutions of lysozyme were used starting with 3600 
µg/mL of lysozyme. Growth analysis was performed in 1 mL culture volumes in 13 mL 
polypropylene round bottom sterile tubes and the OD600nm was determined at 20 h post-
inoculation allowing for MIC determination.   
 
2.8 Polymyxin B MIC 
 Wild-type S. lugdunensis were used to infect M-CSF derived macrophages for a 
typical gentamicin protection assay. At 1.5 hours post infection the macrophages were 
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lysed, and the bacteria were collected. Meanwhile, WT S. lugdunensis that had not been 
exposed to macrophages were diluted to an equal culture density as those collected from 
the macrophages. 20µl of each culture was used to inoculate series of tubes with 2-fold 
dilutions of Polymyxin B in RPMI with 5%FBS. The tubes were incubated at 37°C for 24 
hours before the culture density was measured by its OD600. 
 
2.9 Immunofluorescence Staining of LAMP-1 
Macrophages were infected as above and at the desired time post-infection 
macrophages were fixed with 4% (v/v) paraformaldehyde (PFA) for 20 minutes at room 
temperature. The cells were then permeabilized with ice-cold methanol for 2 minutes and 
then blocked with 1 mL 5% (w/v) skim milk in sterile 1x PBS for at least 1 hour. 
Macrophages were then incubated for 1 hour at room temperature with either mouse anti-
human LAMP-1 antibody (clone H4A3) or with rat anti-mouse LAMP-1 antibody (clone 
1D4B) diluted 1:100 in blocking solution as appropriate. Cells were then rinsed and 
subsequently incubated for 1 hour with 0.75 µg/mL of the appropriate fluorophore 
conjugated secondary antibody diluted in blocking solution and then rinsed. LAMP-1 
immunostained cells were analyzed by confocal or wide-field fluorescence microscopy. 
 
2.10 Dextran Loading of Macrophages 
Macrophages adhered to coverslips were incubated overnight with 10 kDa dextran 
conjugated with FITC or TRITC at 100 μg/mL (Molecular Probes®, Thermo Fisher 
Scientific) in complete tissue culture medium. Prior to infection dextran loaded 
macrophages were washed with PBS and the medium was replaced with serum free RPMI 
without dextran for at least 1 hour to allow for labelling of lysosomal compartments. After 
this, infections were carried out as described above and at 1.5 hours post-infection the cells 
were imaged live on a Leica TCS SP5 laser scanning confocal microscope. 
 
2.11 eFluor Proliferation Assays 
S. lugdunensis containing the pRSA-GFP plasmid were labeled with 5μg/mL 
eBioscience™Cell Proliferation Dye eFluor™ 670 in 0.9% (w/v) saline for 5 minutes. The 
bacteria were then washed with LB to quench the unreacted eFluor dye and were then re-
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suspended in serum free RPMI to carry out infections as described above. At 1.5 and 24 
hours post infection the samples were fixed and imaged by wide field fluorescence 
microscopy. In some instances, macrophages were either pre-treated or treated after 
gentamicin exposure (i.e. 1.5 hours post-infection) with ConA (0.5 µM), DPI (10 µM), 
Pepstatin A (100 µM) and Antipain (10 µg/mL) alone or in combination. Once added, 
pharmacological agents were maintained throughout the entire experiment. In some 
instances, propidium iodide was added to cells (1 µg/mL), which were then were imaged 
live by fluorescence microscopy.    
 
2.12 IgG opsonization and phagocytosis of beads 
 Silica beads (3.14 µm, Bangs Laboratories) were incubated for 1 hour with 0.8 
mg/mL human IgG prior to washing. Next beads were added to macrophages and 
centrifuged at 277 x g to synchronize binding of IgG coated beads to macrophages. After 
a 30-minute incubation at 37°C an ant-human IgG conjugated to AlexaFluor-647 (0.75 
µg/mL) was added to mark extracellular beads prior to fixation with 4% (v/v) 
paraformaldehyde. Macrophages were then imaged by fluorescence microscopy and the 
phagocytic index was determined by counting the number of internalized beads (i.e. 
AlexaFluor-647 negative) divided by the total number of macrophages counted. 
Macrophages without beads adhered to the cell surface were not included in the analysis.  
  
2.13 Cytotoxicity Assay 
 Raw macrophages were seeded on to glass coverslips and incubated overnight 
growing to a cell density of approximately 80% coverage. At the same time overnight 
cultures of S. aureus USA300, S. lugdunensis HKU09-01, and S. lugdunensis N920143 
were grown in TSB. These cultures were centrifuged and then passed through 2 separate 
0.2µm filters to remove the bacteria. 100µL of each culture supernatant as well as a TSB 
control was each added to 900µL of RPMI with 5% FBS and added to separate wells of 
macrophages. The cells were incubated at 37°C with the supernatants for 2 hours at which 
time propidium iodide was added and the cells were imaged live by fluorescent microscopy 
to quantify cell death in each sample.  
 
 
24 
 
 
2.14 Lact-C2 Transfection of RAW macrophages 
 The Lact-C2 expression vector (1µg/mL) was added to the Fugene transfection 
reagent at a ratio of 1µL:3µL in 100uL of serum free DMEM per well of macrophages to 
be transfected. This mixture was vortexed and incubated at room temperature for 10 
minutes. 100µL was added dropwise to each well and the plate was gently shaken to mix. 
The cells were then incubated at 37°C overnight and then used for infections as normal. 
 
2.15 Fluorescence Microscopy 
Laser scanning confocal microscopy was performed using a Leica TC5 SP5 
microscope composed of a DMI6000 CS inverted microscope. The microscope contains an 
argon/2 (458, 476, 488, and 514nm) HeNe1 (543nm) HeNe2 (633nm) lasers and a PL-Apo 
63x oil immersion objective lens. The microscope also contains a triple dichroic 
(488/543/633) a double dichroic (488/543) and a tunable Acousto-Optical Beam Splitter 
for all laser lines. All confocal Imaging was done at the Robarts Research Institute Imaging 
Facility (The University of Western Ontario). 
 Wide field fluorescence and differential interference contrast (DIC) microscopy 
was performed on a Leica DMI6000 B inverted microscope. The microscope is equipped 
with 40x (NA 1.3), 63x (NA 1.4), and 100x (NA 1.4) oil immersion PL-Apo objectives, a 
Leica 100W Hg high-pressure light source and a Photometrics Evolve 512 Delta EM-CCD 
camera. Deconvolution of wide-field images acquired as z-stacks was done using the Leica 
LAS X software. 
 For acquisition of S. lugdunensis in eFluor-670 proliferation assays acquisition 
parameters for far-red fluorescence within each experiment were established on 1.5 h 
samples where all bacteria were eFluor-positive. EM gain (~50), excitation intensity 
(100%), and exposure time (~60 ms) was set to obtain maximal fluorescence without 
achieving saturation of the far-red eFluor-670 signal at the 1.5 time point where the signal 
would be greatest. The acquisition parameters established for each 1.5 h sample were 
applied to the 24 h samples to identify bacteria that had become eFluor-negative due to 
dilution of the dye as a consequence of bacterial replication. Enumeration of replication 
was completed by comparing the number of macrophages containing replicating bacteria, 
defined here as a foci of >1 cocci with total loss of eFluor, to the total number of 
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macrophages containing bacteria. Images were acquired using either the 63x or 100x 
objectives and images were processed using Image J software (127) for contrast 
enhancement always with a gamma setting of 1. Images were cropped as necessary using 
Image J after contrast enhancement and finally scale bars were applied to each image series. 
 
2.16 Transmission Electron Microscopy 
Macrophages infected with S. lugdunensis were fixed with 2% (v/v) glutaraldehyde 
in 0.2M Sorenson’s phosphate buffer (pH 7.2) for 5 minutes after which the cells were 
scraped off the coverslip, pelleted by centrifugation and re-suspended in fixative for an 
additional 2 hours. Fixed macrophages were subsequently embedded in agarose and post-
fixed with 0.5% (w/v) osmium tetroxide for 2 hours at room temperature. Next, cells were 
stained en bloc for 1 hour with 1% (w/v) uranyl acetate in dH2O. Samples were then 
progressively dehydrated with increasing concentrations of acetone and then embedded in 
Epon-Araldite resin. Eighty-nanometer thick sections were cut and placed on copper grids 
to allow viewing with a Philips CM10 transmission electron microscope. Images were 
taken using a Hamamatsu Orca 2 MPx HRL camera. 
 
2.17 Murine model of systemic infection.  
All protocols for murine infection were reviewed and approved by the University 
of Western Ontario’s Animal Use Subcommittee, a subcommittee of the University 
Council on Animal Care. Six-week-old, female, BALB/c mice were obtained from Charles 
River Laboratories and housed in microisolator cages. S. lugdunensis strains were grown 
to exponential phase (OD600 2 - 4) in TSB, washed twice with PBS, and resuspended in 
PBS to an OD600 of 0.50. In instances where S. lugdunensis was heat-inactivated the 
bacterial suspension at an OD600 of 0.5 were heated at 80°C for 30 min and plated on TSA 
to confirm bacterial killing. For injections, 100 µL of the bacterial suspension, equivalent 
to ~2-3 x 107 CFU, was injected into each mouse via tail-vein. After 8 hrs of infection mice 
were anesthetized and euthanized via cervical dislocation. Livers were aseptically 
harvested into ice-cold PBS with 0.1% (v/v) Triton X-100, homogenized, serially diluted 
and plated onto TSA to enumerate bacterial burden. Bacterial burden from liver is 
presented as log10 CFU per liver. 
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 In instances of co-infection, S. lugdunensis was cultured and injected as described 
above. To prepare S. aureus USA300, the bacteria were cultured in TSB until mid-
exponential phase (OD ~2.0-2.5) and then washed twice with sterile 1x PBS. The bacterial 
suspension was diluted to an OD equivalent of 0.3. 100 µL of bacterial suspension, 
equivalent to ~3-4 x 106 CFU, was injected into each mouse via tail-vein. Injections with 
S. aureus USA300 were performed 16 h post-infection with S. lugdunensis. At 8 h post-S. 
aureus infection and a total of 24 h for S. lugdunensis. Mice were euthanized as described 
above and livers were harvested, homogenized and serially diluted. Diluted homogenates 
were plated TSA and MSA and the bacterial burdens, presented as Log10 CFU/mL, were 
determined.     
 
2.18 Intravital spinning disk confocal microscopy 
For whole animal imaging studies experiments were performed with 6–10-wk old 
adult male mice, following protocols approved by the University of Calgary Animal Care 
Committee and in compliance with the Canadian Council for Animal Care Guidelines. All 
animals were maintained in a specific pathogen–free environment at the University of 
Calgary Animal Resource Centre and mice were housed under standardized conditions for 
temperature (21–22°C) and illumination (12 h light/12 h darkness) with constant access to 
tap water and food. 
For injections, a tail vein catheter was inserted into mice anesthetized with 200 
mg/kg ketamine (Bayer Animal Health) and 10 mg kg−1 xylazine (Bimeda-MTC). Surgical 
preparation of the liver for intravital imaging was performed as described previously (128). 
Mouse body temperature was maintained at 37°C with a heated stage and image acquisition 
was performed using Olympus IX81 inverted microscope, equipped with an Olympus 
focus drive and a motorized stage (Applied Scientific Instrumentation). Objectives position 
was controlled with a motorized objective turret equipped with 4×/0.16 UPLANSAPO, 
10×/0.40 UPLANSAPO, and 20×/0.70 UPLANSAPO objective lenses and coupled to a 
confocal light path (WaveFx; Quorum Technologies) based on a modified Yokogawa 
CSU-10 head (Yokogawa Electric Corporation). Kupffer cells were visualized in vivo by 
i.v. injection of 2.5 µg fluorescently conjugated anti–F4-80 mAb (clone BM8). S. 
lugdunensis bacteria were visualized through constitutive expression of GFP and 1.0 x 107 
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bacteria were injected per mouse. Laser excitation wavelengths 491, 561, 642, and 730 nm 
(Cobolt) were used in rapid succession, together with the appropriate band-pass filters 
(Semrock). A back-thinned EMCCD 512 × 512 pixel camera was used for fluorescence 
detection (Hamamatsu). Volocity software (Perkin Elmer) was used to drive the confocal 
microscope and for image acquisition and analysis. The find objects function in Volocity 
software was used to identify individual bacteria that were captured by KCs (F4/80+ cells 
in liver) and to determine the fluorescence intensity per particle. 
 
2.19 Statistical Analysis 
Data are presented as the mean ± SD. All statistical analyses and graph production 
were done through GraphPad Prism (GraphPad Software, La Jolla, CA). Data were 
analyzed using unpaired t-tests or a one-way analysis of variance with either Dunnett’s or 
Bonferroni’s multiple comparison test as indicated. *P<0.05, **P<0.01, ***P<0.001, 
****P<0.0001. 
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CHAPTER 3 – RESULTS 
 
3.1 S. lugdunensis resides within macrophages for extended periods of time without 
replicating.  
To explore the interaction of S. lugdunensis with macrophages, gentamicin 
protection assays were performed using the murine macrophage cell line RAW 264.7 
(hereafter called RAW) and primary human M-CSF-derived macrophages. Macrophages 
were allowed to phagocytose S. lugdunensis HKU09-01 and, at 1.5 hours post-infection 
(after gentamicin treatment), viable S. lugdunensis were recovered from infected RAW and 
primary human cells (Figure 1A-B). At 24 hours post-infection, viable S. lugdunensis was 
recovered from infected macrophages, however, it was evident that the burden of S. 
lugdunensis was unchanged over the 24-hour period (Figure 1A-B). To verify that this 
observation was unique to S. lugdunensis, parallel infections were performed using S. 
aureus USA300 and Micrococcus luteus, representative bacteria previously established to 
overcome macrophage restriction or to be killed, respectively (42). Consistent with 
previous observations M. luteus, although recovered at 1.5 hours post-infection, was 
eradicated by 24 hours (Figure 1A-B). In contrast to S. lugdunensis and M. luteus, S. aureus 
USA300 grew over the same 24-hour period indicating the macrophages failed to restrict 
S. aureus (Figure 1A-B) It is worth noting that S. lugdunensis was able to grow in the tissue 
culture media when no macrophages are present (Figure 1C), indicating the macrophages 
specifically are responsible for restricting S. lugdunensis. To determine whether S. 
lugdunensis could persist intracellularly for an extended period of time, infected primary 
human macrophages were monitored over 72 hours (Fig. 1D). This analysis demonstrated 
that at 48 and 72 hours post-infection, viable S. lugdunensis could be recovered from 
macrophages, although at 72 hours a modest, yet statistically significant decrease in 
bacterial viability was observed (Fig. 1D). 
 eFluor proliferation assays were used to investigate whether S. lugdunensis was in 
equilibrium between growth and death or was truly not replicating within host cells. To 
this end GFP-expressing S. lugdunensis were labelled with the far-red proliferation dye 
eFluor670 such that at the outset of the experiment all phagocytosed bacteria were GFP- 
and eFluor670-positive and those that replicate would dilute and lose the eFluor dye. 
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Primary human M-CSF-derived macrophages, at 1.5 hours post-infection and, remarkably, 
at 24 hours post-infection, contained GFP and eFluor-positive S. lugdunensis exclusively, 
indicating that the bacteria had not replicated at all over this period of time (Figure 1E). 
Taken together these data indicate that S. lugdunensis demonstrates a unique intracellular 
fate as compared to S. aureus and M. luteus wherein the bacteria remain viable within 
macrophages for extended periods of time but do not replicate in this intracellular niche. 
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Figure 1. Macrophages fail to kill intracellular S. lugdunensis but restrict bacterial 
growth. In (A-C) Macrophages/empty wells were infected at an MOI of 10 and the number 
of gentamicin-protected bacteria at 1.5 and 24 hours post-infection was determined. S. 
lugdunensis HKU09-01 was found to survive while, S. aureus USA300 grows and M. 
luteus is killed within RAW 264.7 (A), or M-CSF-derived primary human macrophages 
(B). Part (C) demonstrates that S. lugdunensis can grow in the tissue culture media in the 
absence of macrophages. In (D) S. lugdunensis was shown to survive for as long as 72 
hours post-infection before a decrease in CFUs was observed. The data presented represent 
the mean CFU/mL ± S.D. of three independent experiments. Statistical significance was 
determined by Dunnett’s multiple comparison test where * P <0.05 and ** P <0.01. In (E) 
representative confocal micrographs depict primary human M-CSF-derived macrophages 
(red) at 1.5 (top panels) and 24 hours (bottom panels) post-infection with GFP-expressing 
S. lugdunensis bacteria (green), that were co-labelled with eFluor670-prolfieration dye 
(blue) at an MOI of 10.  White boxes indicate regions displayed in insets, and white arrows 
point to cocci that remain eFluor670-positive, indicating the bacteria have not replicated 
over a 24 hours period. Images are representative of at least three independent experiments, 
scale bars equal 10 µm. 
 
 
3.2 Phagocytosed S. lugdunensis are trafficked to mature phagolysosomes in 
macrophages.  
I next sought to identify the subcellular niche occupied by phagocytosed S. 
lugdunensis. Particulates ingested by macrophages are brought into phagosomes and are 
rapidly matured into lysosome-associated membrane protein 1 (LAMP-1)-positive 
phagolysosomes. To determine whether phagocytosed S. lugdunensis are contained within 
phagolysosomes demarcated by LAMP-1, RAW and primary human M-CSF-derived 
macrophages were infected and immunostained using anti-LAMP-1 antibody to be 
visualized by microscopy. This analysis revealed that at 1.5 hours post-infection the 
majority (~80%) of intracellular S. lugdunensis colocalize with the LAMP-1 protein as 
indicated by the accumulation of anti-LAMP-1 fluorescence around intracellular cocci in 
RAW (Figure 3A) and M-CSF derived macrophages (Figure 2A and C). To confirm that 
ingested S. lugdunensis reside in mature phagolysosomes I also performed dextran pulse-
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chase experiments to fluorescently label lysosomes, which fuse with phagosomes during 
infection. This analysis revealed that in both RAW (Figure 3B) and primary human 
macrophages (Figure 2B and. D), roughly 80% of intracellular S. lugdunensis colocalize 
with lysosomal dextran, identical to LAMP-1. This together shows that intracellular S. 
lugdunensis bacteria are quickly trafficked to and reside within mature phagolysosomes of 
macrophages.  
 
 
Figure 2. S. lugdunensis is trafficked into LAMP-1 and dextran positive 
phagolysosomes. The maturation state of the S. lugdunensis-containing phagosome in 
primary human M-CSF-derived macrophages was analyzed. In (A) Infected cells were 
A)
B)
S. lugdunensis / External LAMP-1 Merge
M
-C
S
F-
de
riv
ed
 
m
ac
ro
ph
ag
es
S. lugdunensisTRITC-Dextran Merge
M
-C
S
F-
de
riv
ed
 
m
ac
ro
ph
ag
es
C) D)
RA
W 
26
4.7
M-
CS
F
0.0
0.2
0.4
0.6
0.8
1.0
Fr
ac
tio
n 
of
 L
A
M
P
-1
 
po
si
tiv
e 
ba
ct
er
ia
 
n.s.
RA
W 
26
4.7
M-
CS
F
0.3
0.4
0.5
0.6
0.7
0.8
0.9 n.s.
Fr
ac
tio
n 
of
 d
ex
tra
n 
po
si
tiv
e 
ba
ct
er
ia
 
 
 
33 
 
 
immunostained demonstrating the accumulation of the LAMP-1 protein (red) around 
eFluor (blue) labeled S. lugdunensis and remaining extracellular were differentiated with 
FITC-avidin (green). In (B) primary human macrophages were loaded with TRITC-dextran 
(in red) that was chased into lysosomes prior to infection with GFP-expressing S. 
lugdunensis (MOI = 10). The white boxes indicate the region of the cells displayed in the 
inset panels and the white arrows point to intracellular S. lugdunensis that are clearly 
demarcated by LAMP-1 (A) or TRITC-dextran (B). In (A) and (B) representative confocal 
micrographs taken from three independent experiments are shown. Scale bars in (A) and 
(B) equal 10 µm. In (C) and (D) the quantitation of intracellular bacteria that from (A) and 
(B) as well as experiments in RAW cells shows that over 80% of intracellular S. 
lugdunensis reside in LAMP-1/dextran positive phagolysosomes at 1.5 hours post 
infection. The data presented are the mean ± S.D and images shown are representative of 
those derived from three independent experiments using primary macrophages from three 
independent donors. n.s. indicates the means are not significantly different as determined 
by a student’s unpaired t test.  
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Figure 3. S. lugdunensis colocalizes with LAMP-1 and lysosomal dextran in RAW 
macrophages.  Similar to before, the intracellular location of S. lugdunensis within RAW 
macrophages was determined through colocalization with endogenous LAMP-1 protein 
(A) and lysosomal dextran (A).  Macrophages were infected with an MOI of 10 and were 
fixed with 4% paraformaldehyde (A) or imaged live (B) at 1.5 hours post infection. Arrows 
indicate staphylococci that are colocalizing with LAMP-1 (red) in (A) and FITC-dextran 
(green) in (B). The white boxes in the lower panel indicate the region of the cell depicted 
in the inset panels. Images shown are confocal (A) and widefield (B) micrographs, that are 
representative of three independent experiments. 
 
3.3 S. lugdunensis resides within Kupffer cells in murine livers. 
Given that S. lugdunensis is able to survive long periods of time when residing 
inside macrophages in vitro, I sought to determine whether or not S. lugdunensis is able to 
inhabit this niche in vivo. To this end,  a systemic murine model of infection was utilized, 
which has previously been established that S. aureus are phagocytosed by, and reside 
within, liver resident Kupffer cells (68). To begin I needed to establish that S. lugdunensis 
could indeed infect the murine liver and reside within Kupffer cells. To this end live GFP-
expressing S. lugdunensis were injected intravenously into anesthetized animals and 
bacterial localization in the liver was monitored over time by intra-vital microscopy (Figure 
4A and B). By 15 minutes post-injection, live GFP-expressing S. lugdunensis were 
visualized in the liver where they colocalized with F4/80+ Kupffer cells (Figure 4A). 
Importantly, GFP-positive S. lugdunensis bacteria were detectable in association with 
F4/80+ Kupffer cells for at least 16 hours post-infection (Figure 4C). Notably, there was no 
evidence that the bacteria were replicating indicated by the absence of any increase in GFP 
fluorescence (Figure 4C). To verify that the bacteria were viable, infections were repeated 
with heat-inactivated GFP-positive S. lugdunensis. Killed S. lugdunensis were rapidly 
captured by F4/80+ Kupffer cells however, unlike live S. lugdunensis, killed S. lugdunensis 
were degraded by 4 hours post-infection as indicated by the absence of detectable GFP 
fluorescence (Fig 4B and C). Together these data revealed that S. lugdunensis is captured 
by Kupffer cells in vivo and that these bacteria can remain viable within these cells long 
after infection.  
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Figure 4. S. lugdunensis are captured by Kupffer cells (KCs) in the murine liver where 
the bacteria resist killing. In (A) and (B) intra vital spinning disk confocal images show 
the capture of live and dead GFP-positive S. lugdunensis. Kupffer cells, marked by their 
labeling with fluorescent F4/80 antibody (in red). Images depict KC/S. lugdunensis 
interaction at 15 min (A) and 4 h post-injection (B). In (C) the presence of live and dead S. 
lugdunensis inside KCs is shown over time. The data were derived from 3 mice for each 
time point with 10 fields of view taken from each mouse and are presented as the mean 
number of GFP-positive S. lugdunensis bacteria detected per field of view ± standard error 
of the mean. Scale bars equal ~20 µm.  
 
3.4 S. lugdunensis is sensitized to exogenous sources of stress after being phagocytosed 
by macrophages. 
The next goal was to identify if that the inability of S. lugdunensis to grow within 
the macrophage could be due to the absence of an essential nutrient that is excluded from 
the phagolysosome. To test this notion infected macrophages were permeabilized after 
A) 
B)
C)
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phagocytosing S. lugdunensis as this would permit access to nutrients in the tissue culture 
medium that would have been excluded from the phagosome. Infections of primary human 
M-CSF-derived macrophages (Figure 5A) or media-only mock infections (Figure 4B) were 
performed where at 1.5 hours post-infection, either vehicle control or 0.02% (v/v) triton X-
100 was added to the culture media and at 24 hours post-infection bacterial proliferation 
was evaluated by plating for colony forming units. Viable S. lugdunensis were recovered 
at 1.5 hours post-infection confirming viable S. lugdunensis were present at the time Triton-
X100 was added to the cultures (Fig. 5A and B). Interestingly, at 24 hours post-infection 
viable S. lugdunensis were only recovered from vehicle control treated macrophages 
(Figure 5A). Surprisingly, in the presence of 0.02% (v/v) triton X-100 the growth of S. 
lugdunensis was not only inhibited but viable bacteria could no longer be detected (Fig. 
5A). This result was surprising given that mock infection experiments demonstrated that 
S. lugdunensis could in fact replicate in the tissue culture media containing either vehicle 
control or 0.02% (v/v) triton X-100 (Fig. 5B), suggesting the macrophages sensitized the 
bacteria to killing by the detergent. To determine whether phagocytosed S. lugdunensis are 
generally more sensitized to exogenous sources of stress, viable S. lugdunensis were 
recovered from infected M-CSF-derived macrophages at 1.5 hours post-infection and 
plated these bacteria (labeled Post) on the permissive medium, tryptic soy agar (TSA, 
Figure 5C right), as well as selective medium, mannitol salt agar (MSA, Figure 5C left). In 
parallel, control S. lugdunensis never having been exposed to macrophages (labeled “Pre”) 
were also plated on TSA and MSA and as expected control bacteria grew equally well on 
both media (Fig. 5C). In contrast, phagocytosed S. lugdunensis grew on TSA but was 
significantly impaired on MSA (Fig. 5C). Furthermore, phagocytosed S. lugdunensis were 
also sensitized to the antimicrobial peptide polymyxin B (PmxB) as S. lugdunensis that had 
been phagocytosed by M-CSF derived macrophages demonstrated increased sensitivity to 
PmxB in liquid culture, relative to control bacteria (Figure 5D) Taken together these 
observations indicate that phagocytosed S. lugdunensis, despite remaining viable, are 
rapidly modified within macrophages in such a way that sensitizes the bacteria to 
exogenous stress. 
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Figure 5. S. lugdunensis demonstrates increased sensitivity to stress in vitro after 
being phagocytosed by macrophages. In (A) M-CSF-derived macrophages were infected 
with S. lugdunensis using an MOI of 10. At 1.5 hours post-infection the cells were treated 
with either vehicle control or 0.02% (v/v) triton X-100 and the resulting colony forming 
units for S. lugdunensis was determined at 24 hours post-infection for the control, sample 
but the triton-treated samples recovered no viable bacteria. The same was done in (B) but 
bacteria were inoculated into tissue culture media lacking macrophages, and all samples 
grew normally. Shown are the mean ± S.D. CFU/mL derived from three independent 
experiments (** P<0.01 **** P<0.0001). In part (C) S. lugdunensis recovered from 
primary human M-CSF-derived macrophages 1.5 hours post-infection (labeled Post) was 
unable to grown on staphylococcal selective mannitol salt agar (left) but grew normally on 
tryptic soy agar (right). As a control S. lugdunensis never having been phagocytosed 
(labeled Pre) is able to grow normally on both types of media. The images are 
representative of three independent experiments. In (D) bacteria were recovered from M-
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CSF derived human macrophages after gentamicin treatment and used to inoculate RPMI 
containing PmxB at the indicated concentrations. S. lugdunensis that have been 
phagocytosed were more sensitive to PmxB than naive S. lugdunensis. These data are the 
mean OD600nm reading ± S.D. from three independent experiments (** P<0.01). 
 
 
3.5 The peptidoglycan acetyl-transferase oatA contributes to the survival of S. 
lugdunensis within macrophages.  
To determine whether the ability of S. lugdunensis to persist within macrophages 
requires the active metabolic function of the bacteria to counter macrophage attack I 
constructed a deletion mutant of S. lugdunensis that lacks the O-acetyl-transferase oatA. 
OatA is responsible for acetylating peptidoglycan, which offers Staphylococcus bacteria 
resistance to lysozyme attack (55). In vitro growth experiments demonstrated that S. 
lugdunensis lacking oatA were ~8 fold more sensitive to lysozyme as compared to wild-
type bacteria (Figure 6A). Indeed, oatA-deficient S. lugdunensis were incapable of growth 
at lysozyme concentrations in excess of 200 µg/mL where as wild-type S. lugdunensis are 
able to grow at lysozyme concentrations ≥ 3200 µg/mL (Fig 6A). Next the oatA mutant 
was analyzed for its ability to survive within RAW macrophages (Figure 6B). To this end 
gentamicin protection assays were performed and at 1.5 hours post-infection wild-type and 
oatA-deficient S. lugdunensis were recovered from macrophages, however at 24 hours 
post-infection it was evident that while WT S. lugdunensis persisted inside the macrophage, 
there was a ~7 fold decrease in CFU/mL at the same time point for the oatA mutant (Fig 
6B). While these data reveal that inside macrophages oatA-deficient S. lugdunensis were 
less able to survive as compared to wild-type, but clearly the bacteria were not eradicated 
entirely. To confirm that oatA is important for survival in vivo, mice were infected 
systemically with wild-type S. lugdunensis and the oatA mutant and the bacterial burden in 
livers was determined at 8 h post-infection (Figure 6C). In agreement with our intra vital 
imaging data it was found that live wild-type S. lugdunensis bacteria were readily recovered 
from livers at 8 h post-infection (Figure 6C). Moreover, I found that significantly fewer 
oatA-deficient S. lugdunensis bacteria were recovered at the same time point (Figure 6C). 
In summary, these data reveal that oatA in S. lugdunensis contributes to lysozyme 
resistance and bacterial survival within macrophages in vitro and in vivo, however clearly 
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there are other factors contributing to the ability of S. lugdunensis to evade immune attack 
within the phagolysosome.  
 
 
Figure 6. Deletion of the oatA gene sensitizes S. lugdunensis to lysozyme and 
intracellular killing in macrophages. In (A) the ability of an oatA to grow in the presence 
of lysozyme in tissue culture media was greatly reduced compared to WT S. lugdunensis. 
These data are the mean OD600 reading ± S.E.M of three biological replicates for each 
strain and are representative of four independent experiments. In (B) Macrophages were 
infected with an MOI of 10 and the CFU/mL for each strain was determined at 1.5 hours 
and 24 hours post-infection, with the oatA mutant having significantly reduction in CFUs 
by 24 hours post-infection compared to WT. These data are the mean ± S.E.M. of at least 
four independent experiments and a total of ten biological replicates. (**** indicates 
p<0.0001, unpaired t test). In (C) the bacterial burdens from murine livers taken from 
BALB/c mice infected with wild-type S. lugdunensis or an oatA-deficient mutant 
demonstrate that the mutant has reduced survival in vivo. Burdens are presented as the 
Log10 CFU/mL. *** indicates p<0.0001 as determined by Student’s t-test. 
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3.6 Perturbation of phagolysosome function enables S. lugdunensis to proliferate with 
Raw macrophages. 
Ostensibly, the rapid restriction of S. lugdunensis by macrophages can be attributed 
to antimicrobial effectors that are active in the phagolysosome. To determine whether 
phagolysosome function is indeed responsible for growth restriction of S. lugdunensis I 
utilized pharmacologic inhibitors known to perturb various effectors that should be active 
during phagocytosis and phagosome maturation. As such macrophages were treated with 
either the vacuolar-ATPase inhibitor Concanamycin A (ConA), the protease inhibitors 
Pepstatin A and Antipain, the NADPH oxidase inhibitor Diphenyleneiodonium (DPI), or a 
combination thereof. Macrophages were left untreated or pre-treated with each inhibitor 
alone or in combination and then infected with S. lugdunensis expressing GFP co-labeled 
with eFluor670 with the inhibitors maintained throughout the infection. It was found that 
inhibitor treatment did promote the proliferative capacity of S. lugdunensis within RAW 
macrophages as GFP-positive eFluor670-negative S. lugdunensis could be visualized 
inside macrophages at 24 hours post-infection (Figure 7A, right panels and B). This was in 
stark contrast to untreated control macrophages where all intracellular bacteria, even at 24 
hours post-infection, remained eFluor670-positive (Figure 7A left panels and B). 
Quantitation of the fraction of macrophages containing replicating bacteria revealed that 
treatment of macrophages with ConA or protease inhibitors alone permitted replication 
within approximately 8 to 12% of macrophages and the simultaneous treatment of 
macrophages with ConA and protease inhibitors did not have an additive effect (Fig 7B). 
Interestingly, the combined treatment of macrophages with each inhibitor, including DPI, 
increased the fraction of cells containing replicating S. lugdunensis to ~ 25-30% despite 
the observation that DPI alone was without effect (Figure 7B).  
To verify that the ability to elicit growth of intracellular S. lugdunensis was 
somewhat unique to this pathogen I next performed infection assays with M. luteus in the 
presence and absence of the same cocktail of inhibitors that allow S. lugdunensis to 
proliferate. In these experiments, M. luteus could be recovered from untreated and inhibitor 
treated cells at 1.5 hours post-infection, but by 24 hours no viable M. luteus could be 
recovered (Figure 8). This shows that intracellular replication due to phagosomal 
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perturbation is at least somewhat specific to S. lugdunensis as the compartment clearly 
maintains a significant level of antimicrobial activity.  
 
3.7 Perturbation of Vps34 in primary human macrophages allows S. lugdunensis to 
replicate intracellularly.  
While the preceding experiments were performed using RAW macrophages I next 
sought to confirm that even in primary human macrophages S. lugdunensis could replicate 
intracellularly. Interestingly, pre-treatment of M-CSF-derived human macrophages with a 
combination of DPI, ConA, Antipain and Pepstatin A failed to promote intracellular growth 
of S. lugdunensis (Fig 7C). Conceivably, the antimicrobial effectors that are expressed or 
the abundance of a given effector differs between RAW and human macrophages and this 
could account for this deviation from our RAW cell data. As an alternate means to perturb 
phagosome function I employed the PI3-kinase inhibitor PIK-III to disrupt Vps34 activity 
and biosynthesis of PI(3)P. The phosphoinositide PI(3)P is an important signaling lipid that 
influences NADPH oxidase function at the phagosome, and participates in phagosome 
maturation and in the formation of autophagosomes (38). Next, I tested the ability of PIK-
III treatment post-phagocytosis to promote S. lugdunensis growth within M-CSF-derived 
human macrophages. As previously observed, macrophages treated with vehicle control 
restricted S. lugdunensis proliferation entirely, however in the presence of PIK-III, GFP-
positive yet eFluor-negative S. lugdunensis could be found within ~22% of the macrophage 
population indicating S. lugdunensis grew intracellularly (Figure 7C). In parallel, anti-
LAMP-1 immunostaining was performed at 2 hours post-infection to establish whether S. 
lugdunensis, in the presence of PIK-III, colocalized with LAMP-1-positive membranes. 
Despite treatment with PIK-III intracellular S. lugdunensis bacteria were found within 
LAMP-1 positive compartments at a nearly equal rate as in untreated cell as visualized by 
confocal microscopy (Fig 7D). These data indicate that pre-treatment of macrophages with 
PIK-III allowed S. lugdunensis to replicate within a significant fraction of primary human 
M-CSF-derived macrophages, however not all aspects of phagosome maturation were 
disrupted upon PIK-III treatment. 
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Figure 7. Pharmacological treatment of S. lugdunensis infected macrophages with 
protease inhibitors enables intracellular bacterial growth. RAW 264.7 macrophages 
were pretreated with 500 nM concanamycin A (v-ATPase inhibitor) alone, Antipain and 
Pepstatin A (protease inh.), 1 µM DPI (NADPH oxidase inhibitor) alone or a combination 
of all inhibitors and infected with GFP-expressing, eFluor (blue) labeled S. lugdunensis. In 
(A) the fluorescent micrographs show vehicle control treated macrophages (red) with 
eFluor-positive S. lugdunensis (left panels) and inhibitor treated macrophages with eFluor-
negative S. lugdunensis (right panels). Representative images from three independent 
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experiments are shown. The white boxes indicate which region of the cell is displayed in 
the inset. In (B) quantitation of the number of macrophages containing replicating bacteria 
in the presence of the various inhibitor treatments is shown for RAW macrophages. In (C) 
M-CSF derived macrophages containing were pretreated with PIK-III (Vps34 inhibitor) 
and infected with S. lugdunensis and the quantitation of macrophages containing 
replicating bacteria is shown. Part (D) shows the fraction of S. lugdunensis that colocalize 
with LAMP-1 in M-CSF derived macrophages at 1.5 hours post infection was not changed 
from control levels when the macrophages were treated with PIK-III. The data are 
presented as the mean ± S.D. calculated from three independent experiments. * P<0.05, 
*** P<0.001.       
 
 
Figure 8. Perturbation of phagosome function does not rescue M. luteus. RAW 
macrophages were infected with M. luteus at an MOI of 10 and gentamicin assays were 
performed to enumerate the number of CFUs. Prior to infection macrophages had been pre-
treated with either PIK-III or a combination of DPI, Antipain, Pepstatin and Concanamycin 
A. These data are the mean CFU/mL ± S.D. from three independent experiments where 
macrophages were lysed at 1.5 and 24 hours post-infection. # Indicates values below the 
limit of detection for these experiments. 
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3.8 Proliferating S. lugdunensis escape phagosomal containment 
 The data presented thus far have shown that we can manipulate the macrophage 
pharmacologically to permit intracellular replication of S. lugdunensis strain HKU09-01. I 
next sought to determine whether replicating S. lugdunensis remain within the 
phagolysosome. LAMP-1 immunofluorescence analyses, performed as before, showed that 
at 24 hours post-infection, using either RAW or primary human macrophages, non-
replicating bacteria remain within LAMP-1-positive compartments (Figure 9A top panels 
and B) while, remarkably and in contrast to what has previously found for S. aureus (42), 
intracellularly replicating S. lugdunensis (i.e. that are eFluor-negative) were rarely 
demarcated LAMP-1 fluorescence (Figure 9A, bottom panels, B and C). It is worth noting 
that the results of the LAMP-1 immunostaining were repeated using S. lugdunensis 
N920143 where eFluor negative bacteria were LAMP-1 negative, and eFluor positive 
bacteria were LAMP-1 positive (Figure 10). This serves to demonstrate that the phenotype 
is not an artefact of the initial strain tested.  
Conceivably, replicating bacteria are no longer constrained by a vacuole, to analyze 
this scenario, RAW macrophages, prior to infection, were transfected with a plasmid 
encoding LactC2-RFP, a biosensor for phosphatidylserine (PS). Importantly, PS is found 
throughout the cell in the cytoplasmic face of the plasma membrane as well as 
compartments comprising the endo/lysosomal network, and numerous vacuolar structures, 
where S. lugdunensis could be located (129). At 24 hours post-phagocytosis, analysis of 
the distribution of LactC2-RFP showed that non-replicating S. lugdunensis and 
phagocytosed IgG-coated beads remained LactC2-RFP positive (Figure 9D top and bottom 
panels). In contrast replicating S. lugdunensis were not demarcated by the Lact-C2 lipid 
biosensor and are thus not in any PS-positive vacuole (Fig 9D middle and bottom panels). 
These latter observations confirm that the exclusion of LactC2-RFP from around 
replicating S. lugdunensis is not due to a global disturbance in PS localization. To confirm 
these observations, macrophages infected with S. lugdunensis were also visualized by 
transmission electron microscopy at 24 h post-infection in the presence and absence of 
inhibitor treatment. This analysis confirmed that non-replicating S. lugdunensis remain 
confined to small vacuoles enclosed by continuous electron dense membrane (Figure 9E). 
In contrast, replicating S. lugdunensis reside in large vacuolar structures containing 
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numerous bacteria and the limiting membrane of these structures appears discontinuous or 
is altogether absent (Figure 9E). 
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Figure 9. Non-replicating S. lugdunensis remain constrained by LAMP-1-positive 
membranes while replicating S. lugdunensis are LAMP-1 and PS negative. RAW 
macrophages were treated with an inhibitor cocktail then infected with S. lugdunensis 
expressing GFP that were labelled with proliferation dye and at 24 hours post-infection 
cells were immunostained for LAMP-1. (A) shows that eFluor-positive S. lugdunensis 
remain LAMP-1 positive (top panels), while eFluor-negative bacteria had become LAMP-
1 negative (bottom panels). In (B) quantitation of the fraction of LAMP-1 positive bacteria 
that are replicating or not replicating is shown. These data presented are the mean ± S.D. 
of at least three independent experiments (student’s unpaired t test, ** P<0.01). Shown in 
(C) the absence of LAMP-1 around replicating S. lugdunensis in primary human M-CSF-
derived macrophages that were treated with PIK-III similar to what was observed in (A). 
This image is representative of three independent experiment. Images are representative of 
three independent experiments. In (D) RAW macrophages expressing the 
phosphatidylserine lipid biosensor LactC2-RFP are shown. LactC2-expressing 
macrophages were treated with an inhibitor cocktail then infected with S. lugdunensis in 
the presence and absence of IgG opsonized beads. In the top panels non-replicating bacteria 
demarcated by LactC2-RFP are shown. In the middle panels replicating S. lugdunensis that 
are devoid of LactC2-RFP are shown, and in the bottom, replicating bacteria are Lact-C2-
negative in the same cell with a Lact-C2-positive bead is shown. These images are 
representative of observations made from four independent experiments. Scale bars equal 
10 µm. In (D) images shown are wide-field micrographs that were subjected to 
deconvolution; the bottom panel is a Z projection of 5 slices through the middle of the 
macrophage. The white asterisks in the bottom panels mark the location of the IgG coated 
bead. In (E) representative transmission electron micrographs of show intact phagosomes 
containing S. lugdunensis in control macrophages (top panel) and discontinuous 
phagosomes in the inhibitor treated macrophages (bottom panel) at 24 h post-infection. 
Black arrows point to intact phagosomal membrane and red arrows point to areas of the 
phagosome where electron dense membrane is compromised. Scale bars equal 4.1 µm.  
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Figure 10. S. lugdunensis N920143 is able to escape phagosomal containment despite 
a lack of toxin production. RAW 264.7 macrophages were infected with the non-
hemolytic strain of S. lugdunensis (N920143) expressing GFP that were labeled with 
eFluor at an MOI of 10. 24 hours post-infection infected cells that were treated with ConA, 
DPI and protease inhibitors together were fixed and immunostained for the LAMP-1 
protein. It was observed that eFluor positive bacteria remain LAMP-1 positive (upper 
panels), but eFluor-negative bacteria become LAMP-1 negative (lower panels), matching 
what was previously observed with S. lugdunensis strain HKU09-01. Images are 
representative of observations from 3 independent experiments. Scale bar=10um, dotted 
line indicates the macrophages plasma membrane 
 
 
3.9 Despite escaping the phagosome replicating S. lugdunensis do not intoxicate the 
host cell. 
Given that phagosomal disruption and release of bacteria into the cytosol is known 
to induce the process of inflammatory cell death known as pyroptosis (130) and that 
replicating S. lugdunensis appear to escape phagosomal containment, I next sought to 
determine whether or not the intracellularly replicating S. lugdunensis were toxic to the 
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host cells. To this end, macrophages, with and without S. lugdunensis infection, were 
treated with vehicle control or a cocktail of inhibitors (ConA, DPI and protease inhibitors) 
that enabled S. lugdunensis growth and were stained with the viability dye propidium 
iodide (PI) to assess integrity of the macrophage plasmalemma and phagocyte viability 
(Figure 11A and B). In these experiments, macrophages were rarely PI-positive (3 to 6%), 
irrespective of pharmacological treatment or infection with S. lugdunensis (Figure 11A and 
B). Given infected macrophages remain refractory to PI, I next determined whether 
infected macrophages are capable of phagocytosis. As before, macrophages were treated 
with and without inhibitors and in the presence and absence of S. lugdunensis infection. 24 
hours post-infection, IgG opsonized latex beads were incubated with control and infected 
macrophages. It was observed that both control and infected macrophages, including those 
containing replicating bacteria, retained their ability to ingest IgG-opsonized phagocytic 
targets (Figure 11C and D and data not shown). These data indicated that in RAW 
macrophages S. lugdunensis even when replicating, presumably in the host cell cytoplasm, 
do not compromise basic macrophage functions.   
 
 
49 
 
 
 
Figure 11. Intracellular replication of S. lugdunensis does not affect macrophage 
viability or function. RAW macrophages were infected with GFP expressing S. 
lugdunensis that were co-labeled with eFluor670 at an MOI of 10. In (A) infected 
macrophages with (upper) and without inhibitor treatments (lower) were stained with 1 µM 
Propidium Iodide (PI) 24 hours post infection; arrows indicate S. lugdunensis that reside 
within PI-negative macrophages. The percent of PI positive cells for each sample was 
quantified at 24 hours in (B) showing no change in the rate of macrophage death for the 
experimental treatments compared to uninfected controls. In (C) macrophages were 
infected with GFP and eFluor labeled S. lugdunensis with (right) and without inhibitor 
treatment (left) for 24 hours after which IgG coated beads were added for 30 minutes. In 
(D) the phagocytic index of infected and uninfected cells was enumerated. Infection with 
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replicating S. lugdunensis had no effect on the ability of the macrophages to undergo 
phagocytosis. Images shown are representative wide-field micrographs and all results are 
obtained from 3 independent experiments. In (B) and (D) n.s. indicates the means are not 
significantly different. Scale bars equal 10 µm. 
 
3.10 S. aureus supernatant is toxic to macrophages and can permit the growth of 
intracellular S. lugdunensis. 
The next goal was to identify more physiologically relevant settings in which S. 
lugdunensis could be coaxed into growth within macrophages. It is well known that S. 
lugdunensis and S. aureus can both reside on human skin and engage in complex 
interactions, and although rare co-infections with S. lugdunensis and S. aureus have been 
reported to occur (72). To begin to investigate the bacterial interactions between these 
species, S. aureus USA300, and S. lugdunensis N920143 and HKU09-01 were streaked 
toward a cross streak of b-toxin producing S. aureus RN4220 on blood agar (Figure 12A). 
S. aureus USA300 is hemolytic and the toxins made by USA300 can synergize with b-
toxin produced by S. aureus RN4220 (Figure 12A). In contrast, S. lugdunensis N920143 is 
non-hemolytic even when in proximity S. aureus RN4220 (Figure 12A). Remarkably, S. 
lugdunensis HKU09-01 which demonstrates a-hemolysis, potently causes red cell lysis 
when growing in proximity to b-toxin producing RN4220 (Figure 12A). When culture 
supernatants from these strains were added to RAW macrophages it was evident that S. 
aureus USA300 is highly toxic as indicated by PI staining of macrophages (Figure 12B 
and C). In contrast, supernatant from S. lugdunensis HKU09-01 and N920134 were non-
toxic, regardless of toxin production, resulting in macrophage PI staining that was 
indistinguishable from a TSB control (Figure 12B and C). Due to its cytolytic ability, 
supernatant from S. aureus USA300 was added to macrophages 1.5 h after infection with 
S. lugdunensis HKU09-01 as a mock co-infection. Treatment with USA300 supernatant 
led to roughly a ~100-fold increase in S. lugdunensis compared to control treated cells by 
24 h post-infection (Figure 12D). These data reveal that toxins produced by extracellular 
S. aureus during a co-infection could exacerbate S. lugdunensis infection by intoxicating 
infected macrophages and allowing release of phagocytosed S. lugdunensis. 
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Figure 12. Intracellular S. lugdunensis can proliferate upon macrophage intoxication 
by S. aureus supernatant. In (A) the hemolytic activity and b-toxin synergy for S. aureus 
USA300, S. lugdunensis HKU09-01 and S. lugdunensis N920134 cultured on TSA with 
5% (v/v) sheep blood agar is shown. Synergy is evident for USA300 and HKU09-01 in 
proximity to S. aureus RN4220. In (B) the effect of culture supernatants, derived from the 
strains in (A), on macrophage viability is shown. The graph depicts the average number of 
propidium iodide (i.e. necrotic cells) positive cell remaining adhered to coverslips for 
image analysis. The data presented are the mean ± S.D of three independent experiments. 
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PI staining was performed 2 hr after the addition of 10% (v/v) culture supernatant or the 
TSB control. # Indicates a large fraction of macrophages had detached from the coverslip 
and were not quantifiable by microscopy indicating many more macrophages had become 
intoxicated by the S. aureus supernatant. This is also evident by the lower apparent cell 
density for the USA300 supernatant treated condition in the representative images 
presented in (C). In (D) the effect of S. aureus USA300 supernatant on S. lugdunensis 
growth from infected macrophages is shown.  Input represents the number of S. 
lugdunensis HKU09-01 bacteria residing within macrophages and were protected from 
gentamicin at 1.5 h post-infection. After gentamicin treatment S. lugdunensis infected 
macrophages were treated with either TSB control (10% v/v) or S. aureus USA300 derived 
supernatant (10% v/v) for 22.5h. At 24 h the bacterial burden for each was determined and 
represents the growth of bacteria inside and outside macrophages as the bacteria are 
liberated from dying macrophages. (*** denotes P<0.001 and statistical significance was 
established by a student t-test). 
 
3.11 The growth of both S. lugdunensis and S. aureus is enhanced during in vitro co-
infections. 
To determine whether S. lugdunensis passively survives or remains virulent within 
macrophages I next performed co-infection experiments where I monitored the impact of 
a co-infection on the replication of intracellular S. lugdunensis and S. aureus. For these co-
infections macrophages were first infected with S. lugdunensis, then the S. lugdunensis-
containing macrophages were infected with S. aureus USA300 12 hours after phagocytosis 
of S. lugdunensis (Figure 13). As controls, macrophages with S. lugdunensis were left 
unexposed to S. aureus USA300 or cells were infected with S. aureus in the absence of S. 
lugdunensis. Previously our lab has demonstrated that S. aureus exhibits significantly 
delayed growth within macrophages, with replication becoming evident at ~10-12 hours 
post infection (42). However, analysis of co-infections revealed that the intracellular 
growth of S. aureus is accelerated when macrophages have already been infected with S. 
lugdunensis as compared to S. aureus infection alone (Figure 13A, C and E). Indeed, by 6 
hours post-infection when both bacterial species are present S. aureus proliferation is 
evident within ~5% of infected macrophages, whereas replication of S. aureus was not 
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evident at the same time point in the absence of intracellular S. lugdunensis (Fig 13A and 
E). Also consistent with our previous observations S. lugdunensis alone failed to replicate 
within macrophages (Figure 13B and D) while, in contrast, with S. aureus co-infection, 
replicating S. lugdunensis can be observed within ~ 3-4% of S. lugdunensis infected 
macrophages after only 6 hours in the absence of pharmacologic intervention (Figure 13B 
and F). These data indicate that although most intracellular bacteria do not replicate, S. 
lugdunensis are not entirely passive after being phagocytosed by macrophages and in the 
presence of S. aureus both bacterial species can exhibit enhanced growth. 
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Figure 13. Co-infection of macrophages with S. lugdunensis and S. aureus augments 
the intracellular replication of both species.  Macrophages were infected with S. 
lugdunensis expressing mCherry or S. aureus expressing GFP alone or were sequentially 
added in a co-infection described in the methods. (A) and (B) show that the percentage of 
macrophages containing replicating S. aureus USA300 (A) or S. lugdunensis HKU09-01 
(B) is significantly increased during co-infection compared each species alone. Replication 
was assessed by fluorescence proliferation assay and bacterial growth was analyzed 6 h 
after the addition of S. aureus. In (A) and (B) the data are the mean ± standard deviation of 
three independent experiments. Statistical significance was determined by students t-test 
where * indicates P<0.05 and ** indicates p<0.01. Representative images for each of the 
infections are shown in C-F in order; (C) S. aureus mono-infection, (D) S. lugdunensis 
mono-infection, (E) and (F) both show a coinfection demonstrating replicating S. aureus 
and S. lugdunensis respectively. Inset panels are magnified images of the boxed regions 
and scale bars are equal to 10μm.  
 
 
3.12 S. lugdunensis infection significantly increases S. aureus burden in the livers of 
mice. 
Following the observation that S. lugdunensis can indeed survive within Kupffer 
cells for extended periods, I next sought to determine whether prior S. lugdunensis infection 
could enhance S. aureus infection in the liver as would be inferred from our in vitro co-
infection data (Fig. 13A and E). To this end, S. lugdunensis HKU09-01 was injected into 
mice via the tail vein 16h prior to S. aureus USA300 and, at 8 h post-infection with S. 
aureus (24 h after S. lugdunensis), the livers of infected animals were removed, and the 
bacterial burden was determined. These infections were compared to those of mice infected 
with either S. lugdunensis or S. aureus alone. It is worth noting that when S. lugdunensis 
alone was used to infect the mice, bacteria could still be recovered 24 hours post infection, 
consistent with what was previously observed with intravital microscopy (Figure 3). 
Moreover, it was discovered that co-infection with S. lugdunensis HKU09-01 and S. aureus 
USA300 resulted in a significantly higher burden for S. aureus in the livers of mice, 
compared to those infected with an equal number of S. aureus alone (Figure 14A). 
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Considering, S. lugdunensis HKU09-01 is hemolytic and shows synergy with b-toxin 
producing S. aureus (see Fig. 12A) I also tested whether the non-hemolytic S. lugdunensis 
N920143 would produce a similar response during murine infections. Once again, prior 
infection with the non-hemolytic S. lugdunensis strain N920143 augmented S. aureus 
infection as compared to S. aureus infection alone (Fig. 14B). To begin to understand how 
S. lugdunensis might enhance S. aureus growth I performed similar co-infection 
experiments where mice were injected with either live or dead S. lugdunensis at 10-fold 
dilutions of cell densities, starting at 5x107, prior to injection of S. aureus. Injection of the 
maximum dose of live or dead S. lugdunensis, into the tail vein, prior to S. aureus infection 
significantly increased the burden of S. aureus in the liver as compared to S. aureus alone 
(Figure 14C). In contrast, when 10-fold fewer live or dead S. lugdunensis are injected prior 
to S. aureus infection, only live S. lugdunensis at this density augmented subsequent S. 
aureus growth in the liver (Figure 14C). Finally, injection of 5x105 or fewer live or dead 
S. lugdunensis fails to elicit this effect and the burden of S. aureus in the liver is not 
different from S. aureus alone (Figure 14C). Taken together, these data are consistent with 
the notion that S. lugdunensis is not benign and that a reservoir of S. lugdunensis in Kupffer 
cells remain virulent for significant time after being phagocytosed and can exacerbate 
infection by S. aureus in vivo. 
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Figure 14. S. lugdunensis bacteria enhance S. aureus infection of the murine liver. In 
(A) The bacterial burden from the livers of mice infected with either the hemolytic S. 
lugdunensis HKU09-01 or S. aureus USA300 alone, or S. lugdunensis HKU09-01 and S. 
aureus USA300 together are shown. The counts from co-infected livers are for S. aureus 
CFUs only, but are significantly increased in the co-infected livers, compared to those 
infected with S. aureus alone.  The data are presented as Log10 CFU/mL with each symbol 
representing a single animal. The horizontal bar represents the mean Log10 CFU/mL value 
with the stander error shown. Burdens were determined at 8 h post-S. aureus infection 
which was injected 16 h post-S. lugdunensis infection. In (B) the burden of S. aureus 
coming from livers containing the non-hemolytic S. lugdunensis N920143 and S. aureus 
USA300 or just S. aureus USA300 alone. As in (A) the counts for co-infected livers are of 
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S. aureus only and are increased compared to the livers with only S. aureus. The data are 
presented as Log10 CFU/mL and each symbol represents one animal. Horizontal bar 
represents the mean Log10 value with the standard error and the burdens were determined 
at 8 h post-S. aureus infection. ***p<0.0001, students t-test. In (C) similar infections were 
performed as in (A) and (B) however live or dead S. lugdunensis HKU09-01 were injected 
via tail vein 16 h prior to S. aureus infection. 1x represents undiluted S. lugdunensis 
injected (5x107 bacteria) and 0.1x, 0.01x and 0.001x represent sequential 10-fold dilutions 
of live or dead S. lugdunensis bacteria that were injected into mice. The addition of the 
maximum or 10-fold diluted dose of live S. lugdunensis was sufficient to increase the S. 
aureus burden, while only the maximum dose of dead S. lugdunensis led to an increase in 
S. aureus.  Each symbol represents a single animal. The data presented as described for (A) 
and (B) above. Statistical significance was determined by one-way ANOVA, with a 
Bonferroni post hoc test where ** P<0.01 and **** p<0.0001. 
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CHAPTER 4 – DISCUSSION AND FUTURE DIRECTIONS 
 
 S. lugdunensis is part of the normal human skin flora (69,72), that has emerged as 
an opportunistic pathogen with the capability to cause severe disease. It has become clear 
that S. lugdunensis is unique among CoNS in its ability to cause infection (70,131,132). 
Along with the ability to cause severe infections, antibiotic resistant strains of S. 
lugdunensis have begun to be found around the world (75,77,91,92). Despite the emergence 
of this species as a significant human pathogen there has been relatively little research 
regarding the pathogenic mechanisms of this species and few virulence factors have been 
identified (82,88,133,134). This study demonstrates that acetylation of the peptidoglycan 
by oatA contributes to the ability of S. lugdunensis to evade killing by host macrophages 
both in vitro and in vivo (67). Within macrophages S. lugdunensis was found to inhabit the 
mature phagolysosome for extended periods of time although was unable to replicate. 
Notably, S. lugdunensis could be coaxed to replicate by inhibiting the v-ATPase or 
lysosomal proteases and following replicating S. lugdunensis was found to escape 
phagolysosomal containment (67). Furthermore, it was found that S. lugdunensis is able to 
potentiate the virulence of S. aureus in both in vitro and in vivo coinfection models. 
 S. lugdunensis clearly does not possess the same arsenal of virulence factors as 
other successful pathogens such as S. aureus, or Salmonella enterica serovar Typhimurium 
(42,135), but still manages to cause serious infections. Moreover, the ability of S. 
lugdunensis to persist within macrophages for extended periods of time is a key aspect of 
what defines a pathogen according to “the macrophages paradox” (136). It is important to 
recognize the ability of macrophages to restrict the growth of S. lugdunensis as an 
antibacterial phenotype, although the inability to eliminate S. lugdunensis indicates that the 
bacteria are able, in some capacity, to circumvent antimicrobial aspects of the 
phagolysosome. This is supported by the observation that inactivation of oatA renders S. 
lugdunensis more susceptible to macrophage killing in vitro and in vivo. Interestingly, 
oatA-deficient bacteria are not entirely eradicated, indicating that other factors must also 
contribute to intracellular survival of S. lugdunensis. Intracellular persistence could 
possibly allow S. lugdunensis to utilize host macrophages as a bacterial reservoir allowing 
S. lugdunensis to avoid immune detection. If the integrity of S. lugdunensis-containing 
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macrophages were to become compromised by some external factor viable S. lugdunensis 
could conceivably be released seeding secondary infections.  In support of this notion this 
report has shown that toxins produced by S. aureus can intoxicate S. lugdunensis-
containing macrophages promoting the outgrowth of S. lugdunensis. Furthermore, it was 
demonstrated that S. lugdunensis, just like S. aureus, is rapidly taken up by Kupffer cells 
(68) and survives within the murine liver for at least 24 hours, highlighting the importance 
of intracellular survival in the context of systemic infections. This finding also speaks to 
the potential for co-infections with S. lugdunensis and S. aureus, as both species are able 
to cause invasive infections, and inhabit the same niche during systemic infections in 
mouse models. 
 On occasions when S. lugdunensis is able to infect a host, it tends to result in highly 
virulent infections that are clinically similar to S. aureus, although S. aureus is a much 
more common cause of infections. Notably, these species inhabit the same intracellular 
niche, but the inability of S. lugdunensis to replicate within macrophages represents a 
significant difference in the pathogenesis of these species. It is possible that the lower rate 
of infections caused by S. lugdunensis represents an inability to effectively gather iron 
contributing to a lack of intracellular growth. As reviewed previously, S. lugdunensis 
encodes the HtsA and SirA receptors for utilization of the SA and SB siderophores 
produced by S. aureus (95), but is incapable of synthesizing these siderophores on its own. 
This suggests that S. lugdunensis would exist in an iron limited state within the host, as 
humans have evolved effective mechanisms for sequestering iron away from microbes 
(32). Co-infection with S. aureus could potentially lead to enhanced growth of S. 
lugdunensis by means of xenosiderophore usage, as co-culture experiments have 
demonstrated the growth promotion of S. lugdunensis by S. aureus when iron was limited 
(95). The observation that S. lugdunensis can be permitted to replicate intracellularly by 
inhibiting the v-ATPase or lysosomal proteases serves to show that iron-limitation is 
clearly not the sole factor restricting the growth of S. lugdunensis. However, S. lugdunensis 
may still be limited by its access to available iron as replicating S. lugdunensis remained 
confined to the host cell for 24 hours, whereas S. aureus are able to grow to high enough 
numbers to kill and emerge from the macrophage (42). The various iron acquisition 
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mechanisms employed by S. lugdunensis remain an area of active investigation and the 
role iron plays in the pathogenesis of this species remains to be seen. 
 The fact that treatment of macrophages with ConA, Pepstatin A and antipain, or 
PIK-III to inhibit, acidification, proteases or Vps34 implies that a yet to be identified 
protease that is active in the phagolysosome is responsible for preventing intracellular 
replication by S. lugdunensis. Presumably ConA permits intracellular replication by 
indirectly inhibiting protease activity in the phagosome. Many phagosomal proteases 
function optimally at acidic pH  (31,137), so ConA treatment would hinder the activity of 
several proteases, including those inhibited by Pepstatin A and antipain, suggesting a 
protease is the true restrictive factor. Furthermore, treatment of either RAW or primary 
human macrophages with PIK-III allowed for replication by S. lugdunensis. By blocking 
Vps34 activity PIK-III functions to arrest phagosome maturation preventing the formation 
of the phagolysosome (38). Because S. lugdunensis is able to replicate in the arrested 
phagosome, the specific factor responsible for growth restriction must only be active in the 
mature phagolysosome. Unfortunately, treatment of S. lugdunensis-containing primary 
human cells with ConA in addition to DPI, Pepstatin A and antipain, did not permit 
intracellular replication. This serves to highlight the functional differences between RAW 
and primary human macrophages and underscores the importance of replicating results in 
primary cells for infection models.   
 In contrast to other pathogens like M. tuberculosis or Legionella pneumophila 
(37,138), this work has shown that S. lugdunensis is unable to perturb phagosome 
maturation, and instead resides within mature phagolysosomes similar to S. aureus (42). 
However, when S. lugdunensis is coaxed to replicate by inhibiting phagosomal effectors 
the bacteria are able to escape phagosomal containment, reminiscent of L. monocytogenes 
(39). Dissolution of the phagosomal membrane should allow increased access to the host 
cell cytoplasm and the nutrients that are actively sequestered away from the phagosome, 
which should support bacterial replication. Conversely, it would be expected that the host 
cell could detect and respond to the cytosolic bacteria leading to the induction of 
inflammatory cell death known as pyroptosis as a way to limit cytosolic bacteria (127). 
However, macrophages containing replicating S. lugdunensis at 24 hours post-infection 
appear healthy and showed no signs of pyroptosis. Furthermore, these macrophages 
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showed no obvious functional impairment as they retained the ability to phagocytose equal 
to uninfected cell. It is tantalizing to speculate about the ability of intracellular S. 
lugdunensis to actively interfere with inflammasome activation in order to sustain its 
intracellular survival. This possibility is not unprecedented as other bacterial pathogens are 
able to either avoid detection by the host cell or actively inhibit inflammasome formation 
(139). Unfortunately, it remains unknown how S. lugdunensis is able to both escape the 
phagosome and avoid the induction of pyroptosis. 
 While S. lugdunensis is an important pathogen with the ability to cause severe 
infections on its own, it has now been demonstrated that S. lugdunensis has the ability to 
enhance the growth of S. aureus during a co-infection both in vitro and in vivo. During the 
in vitro co-infections it was found that both S. lugdunensis and S. aureus were able to 
benefit from the presence of each other. It was observed that S. lugdunensis was able to 
initiate intracellular replication, which was absent in mono infections, and S. aureus was 
able to begin replicating much quicker in co-infected cells compared to mono-infected cells 
(42,67). Importantly the beneficial effect conferred to S. aureus, by S. lugdunensis was 
recapitulated in vivo. Based on the results obtained from the in vitro experiments it would 
also be expected that S. lugdunensis may be able to better replicate within the co-infected 
livers leading to an increase in CFU. Unfortunately, during the in vivo co-infections only 
the CFUs for S. aureus were able to be counted. The reason for this is that when plating 
the lysate from the mixed infections S. aureus is able to grow much faster on TSA plates 
than S. lugdunensis. This means when colonies became visible for counting, only S. aureus 
was visible and by the time S. lugdunensis colonies would have grown they would have 
been overshadowed by the growth of S aureus. In order to determine the number of S. 
lugdunensis CFUs in our co-infection samples, an antibiotic resistance cassette could be 
knocked in to the chromosome of S. lugdunensis. Then by plating the mixed infection 
lysates side by side on TSA plates and TSA plates with antibiotics, the S. lugdunensis 
colonies would be selected for, allowing for CFU determination. This will allow us to 
determine if these two species offer each other a benefit during in vivo infections, similar 
to what was observed in vitro, or if S. aureus is the sole beneficiary of this interaction. 
Regardless the ability of S. lugdunensis to potentiate the virulence of S. aureus is an 
interesting phenotype that is the polar opposite of the interactions of these species during 
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colonization (96). This serves to highlight the role that environmental context plays in 
shaping the interactions between different bacterial species. Furthermore, the ability to 
enhance the virulence of a pathogen such as S. aureus is a significant finding and is 
expected to generate great interest into the outcomes of co-infections between these as well 
as other important pathogenic species.  
 While the observations in this thesis are expected to generate significant interest, 
there is still a lot of work to be completed. It was demonstrated that oatA contributes to 
intracellular survival but there are clearly other factors that remain to be identified that 
permit low level persistence in the absence of oatA. Additionally, the ability of S. 
lugdunensis to escape phagosomal containment is a significant difference from S. aureus, 
and likely requires the action of a yet to be identified virulence factor. It is possible that the 
factor allowing for phagosomal escape is a pore forming toxin or phospholipase of some 
sort, similar to the machinery employed by L. monocytogenes for phagosomal escape (39–
41), although further work is required to characterize the escape mechanism employed by 
S. lugdunensis. Lastly, it is not known whether S. lugdunensis confers a growth benefit to 
S. aureus by directly interacting with S. aureus, or if S. lugdunensis is able to affect the 
macrophages making them more hospitable towards S. aureus during co-infection. These 
questions remain areas of active investigation within the lab. 
 In summary S. lugdunensis is an important emerging CoNS species that stands out 
for its ability to cause severe infections. This work has shown that S. lugdunensis is not 
killed by macrophages but rather is able to persist within the mature phagolysosome for 
extended periods of time without intoxicating the host cell. The ability of this species to 
survive intracellularly without killing the host cell suggests that this bacterium could be 
using host phagocytes as a “trojan horse” allowing them to evade detection by the immune 
system. This evasion could then contribute to the dissemination of infection if S. 
lugdunensis were to be released from the macrophages due to some external factors, such 
as a co-infection. In support of this S. lugdunensis was able to replicate when co-infecting 
with S. aureus and the addition of S. aureus’ toxins to S. lugdunensis containing cells 
resulted in the release and growth of S lugdunensis. Together this work supports the notion 
that S. lugdunensis could indeed utilize host macrophages as a bacterial reservoir.  
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